<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />

<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="author" content="Matteo Delucchi" />

<meta name="date" content="2019-05-21" />

<title>Tandem Repeats in Colorectal Cancer</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
div.sourceCode { overflow-x: auto; }
table.sourceCode, tr.sourceCode, td.lineNumbers, td.sourceCode {
  margin: 0; padding: 0; vertical-align: baseline; border: none; }
table.sourceCode { width: 100%; line-height: 100%; }
td.lineNumbers { text-align: right; padding-right: 4px; padding-left: 4px; color: #aaaaaa; border-right: 1px solid #aaaaaa; }
td.sourceCode { padding-left: 5px; }
code > span.kw { color: #007020; font-weight: bold; } /* Keyword */
code > span.dt { color: #902000; } /* DataType */
code > span.dv { color: #40a070; } /* DecVal */
code > span.bn { color: #40a070; } /* BaseN */
code > span.fl { color: #40a070; } /* Float */
code > span.ch { color: #4070a0; } /* Char */
code > span.st { color: #4070a0; } /* String */
code > span.co { color: #60a0b0; font-style: italic; } /* Comment */
code > span.ot { color: #007020; } /* Other */
code > span.al { color: #ff0000; font-weight: bold; } /* Alert */
code > span.fu { color: #06287e; } /* Function */
code > span.er { color: #ff0000; font-weight: bold; } /* Error */
code > span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
code > span.cn { color: #880000; } /* Constant */
code > span.sc { color: #4070a0; } /* SpecialChar */
code > span.vs { color: #4070a0; } /* VerbatimString */
code > span.ss { color: #bb6688; } /* SpecialString */
code > span.im { } /* Import */
code > span.va { color: #19177c; } /* Variable */
code > span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code > span.op { color: #666666; } /* Operator */
code > span.bu { } /* BuiltIn */
code > span.ex { } /* Extension */
code > span.pp { color: #bc7a00; } /* Preprocessor */
code > span.at { color: #7d9029; } /* Attribute */
code > span.do { color: #ba2121; font-style: italic; } /* Documentation */
code > span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code > span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code > span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' || rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<link href="data:text/css;charset=utf-8,body%20%7B%0Abackground%2Dcolor%3A%20%23fff%3B%0Amargin%3A%201em%20auto%3B%0Amax%2Dwidth%3A%20700px%3B%0Aoverflow%3A%20visible%3B%0Apadding%2Dleft%3A%202em%3B%0Apadding%2Dright%3A%202em%3B%0Afont%2Dfamily%3A%20%22Open%20Sans%22%2C%20%22Helvetica%20Neue%22%2C%20Helvetica%2C%20Arial%2C%20sans%2Dserif%3B%0Afont%2Dsize%3A%2014px%3B%0Aline%2Dheight%3A%201%2E35%3B%0A%7D%0A%23header%20%7B%0Atext%2Dalign%3A%20center%3B%0A%7D%0A%23TOC%20%7B%0Aclear%3A%20both%3B%0Amargin%3A%200%200%2010px%2010px%3B%0Apadding%3A%204px%3B%0Awidth%3A%20400px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Aborder%2Dradius%3A%205px%3B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Afont%2Dsize%3A%2013px%3B%0Aline%2Dheight%3A%201%2E3%3B%0A%7D%0A%23TOC%20%2Etoctitle%20%7B%0Afont%2Dweight%3A%20bold%3B%0Afont%2Dsize%3A%2015px%3B%0Amargin%2Dleft%3A%205px%3B%0A%7D%0A%23TOC%20ul%20%7B%0Apadding%2Dleft%3A%2040px%3B%0Amargin%2Dleft%3A%20%2D1%2E5em%3B%0Amargin%2Dtop%3A%205px%3B%0Amargin%2Dbottom%3A%205px%3B%0A%7D%0A%23TOC%20ul%20ul%20%7B%0Amargin%2Dleft%3A%20%2D2em%3B%0A%7D%0A%23TOC%20li%20%7B%0Aline%2Dheight%3A%2016px%3B%0A%7D%0Atable%20%7B%0Amargin%3A%201em%20auto%3B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dcolor%3A%20%23DDDDDD%3B%0Aborder%2Dstyle%3A%20outset%3B%0Aborder%2Dcollapse%3A%20collapse%3B%0A%7D%0Atable%20th%20%7B%0Aborder%2Dwidth%3A%202px%3B%0Apadding%3A%205px%3B%0Aborder%2Dstyle%3A%20inset%3B%0A%7D%0Atable%20td%20%7B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dstyle%3A%20inset%3B%0Aline%2Dheight%3A%2018px%3B%0Apadding%3A%205px%205px%3B%0A%7D%0Atable%2C%20table%20th%2C%20table%20td%20%7B%0Aborder%2Dleft%2Dstyle%3A%20none%3B%0Aborder%2Dright%2Dstyle%3A%20none%3B%0A%7D%0Atable%20thead%2C%20table%20tr%2Eeven%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Ap%20%7B%0Amargin%3A%200%2E5em%200%3B%0A%7D%0Ablockquote%20%7B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Apadding%3A%200%2E25em%200%2E75em%3B%0A%7D%0Ahr%20%7B%0Aborder%2Dstyle%3A%20solid%3B%0Aborder%3A%20none%3B%0Aborder%2Dtop%3A%201px%20solid%20%23777%3B%0Amargin%3A%2028px%200%3B%0A%7D%0Adl%20%7B%0Amargin%2Dleft%3A%200%3B%0A%7D%0Adl%20dd%20%7B%0Amargin%2Dbottom%3A%2013px%3B%0Amargin%2Dleft%3A%2013px%3B%0A%7D%0Adl%20dt%20%7B%0Afont%2Dweight%3A%20bold%3B%0A%7D%0Aul%20%7B%0Amargin%2Dtop%3A%200%3B%0A%7D%0Aul%20li%20%7B%0Alist%2Dstyle%3A%20circle%20outside%3B%0A%7D%0Aul%20ul%20%7B%0Amargin%2Dbottom%3A%200%3B%0A%7D%0Apre%2C%20code%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0Aborder%2Dradius%3A%203px%3B%0Acolor%3A%20%23333%3B%0Awhite%2Dspace%3A%20pre%2Dwrap%3B%20%0A%7D%0Apre%20%7B%0Aborder%2Dradius%3A%203px%3B%0Amargin%3A%205px%200px%2010px%200px%3B%0Apadding%3A%2010px%3B%0A%7D%0Apre%3Anot%28%5Bclass%5D%29%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Acode%20%7B%0Afont%2Dfamily%3A%20Consolas%2C%20Monaco%2C%20%27Courier%20New%27%2C%20monospace%3B%0Afont%2Dsize%3A%2085%25%3B%0A%7D%0Ap%20%3E%20code%2C%20li%20%3E%20code%20%7B%0Apadding%3A%202px%200px%3B%0A%7D%0Adiv%2Efigure%20%7B%0Atext%2Dalign%3A%20center%3B%0A%7D%0Aimg%20%7B%0Abackground%2Dcolor%3A%20%23FFFFFF%3B%0Apadding%3A%202px%3B%0Aborder%3A%201px%20solid%20%23DDDDDD%3B%0Aborder%2Dradius%3A%203px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Amargin%3A%200%205px%3B%0A%7D%0Ah1%20%7B%0Amargin%2Dtop%3A%200%3B%0Afont%2Dsize%3A%2035px%3B%0Aline%2Dheight%3A%2040px%3B%0A%7D%0Ah2%20%7B%0Aborder%2Dbottom%3A%204px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Apadding%2Dbottom%3A%202px%3B%0Afont%2Dsize%3A%20145%25%3B%0A%7D%0Ah3%20%7B%0Aborder%2Dbottom%3A%202px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Afont%2Dsize%3A%20120%25%3B%0A%7D%0Ah4%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23f7f7f7%3B%0Amargin%2Dleft%3A%208px%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Ah5%2C%20h6%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23ccc%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Aa%20%7B%0Acolor%3A%20%230033dd%3B%0Atext%2Ddecoration%3A%20none%3B%0A%7D%0Aa%3Ahover%20%7B%0Acolor%3A%20%236666ff%3B%20%7D%0Aa%3Avisited%20%7B%0Acolor%3A%20%23800080%3B%20%7D%0Aa%3Avisited%3Ahover%20%7B%0Acolor%3A%20%23BB00BB%3B%20%7D%0Aa%5Bhref%5E%3D%22http%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0Aa%5Bhref%5E%3D%22https%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0A%0Acode%20%3E%20span%2Ekw%20%7B%20color%3A%20%23555%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Edt%20%7B%20color%3A%20%23902000%3B%20%7D%20%0Acode%20%3E%20span%2Edv%20%7B%20color%3A%20%2340a070%3B%20%7D%20%0Acode%20%3E%20span%2Ebn%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Efl%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Ech%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Est%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Eco%20%7B%20color%3A%20%23888888%3B%20font%2Dstyle%3A%20italic%3B%20%7D%20%0Acode%20%3E%20span%2Eot%20%7B%20color%3A%20%23007020%3B%20%7D%20%0Acode%20%3E%20span%2Eal%20%7B%20color%3A%20%23ff0000%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Efu%20%7B%20color%3A%20%23900%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%20code%20%3E%20span%2Eer%20%7B%20color%3A%20%23a61717%3B%20background%2Dcolor%3A%20%23e3d2d2%3B%20%7D%20%0A" rel="stylesheet" type="text/css" />




</head>

<body>




<h1 class="title toc-ignore">Tandem Repeats in Colorectal Cancer</h1>
<h3 class="subtitle">Characterization and Functional Analysis of Tandem Repeat</h3>
<h4 class="author">Matteo Delucchi</h4>
<h4 class="date">May 21, 2019</h4>



<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>In Switzerland, colorectal cancer is among the top 3 leading cause for cancer-related mortality <a href="https://www.krebsliga.ch/ueber-krebs/krebsarten/dickdarmkrebs/">1</a>. As the disease shows varying clinical outcomes and therapeutic responses, researchers try through personalized medicine to find individually optimal treatments.</p>
<p>The development of colorectal cancer (CRC) is accompanied by genetic and epigenetic mutations in onco- and tumor-suppressor genes which are supposed to cause CRC onset, progression and metastasis <a href="http://dx.doi.org/10.1155/2012/509348">2</a> <a href="http://dx.doi.org/10.1136/flgastro-2013-100329">3</a>.</p>
<p>Some clinical relevant biomarkers are today already used as prognostic and/or therapeutic predictive markers <a href="https://doi.org/10.3892/or.2015.4108">4</a>.</p>
<div id="colorectal-cancer-on-a-molecular-level" class="section level2">
<h2>Colorectal Cancer on a Molecular Level</h2>
<p>Undifferentiated cells, such as colon stem progenitor cells, are located at the bottom of a crypt in healthy colons. They are able of self-renewal and pluripotency. During their live-cycle of about 14 days, they differentiate in all epithelial colon cell lineages (Paneth, goblet, enterocytes and enteroendocrine) while migrating from the crypt to the top of the villus leading into apoptosis <a href="https://doi.org/10.1073/pnas.0707210104">5</a>. The maintenance of genomic integrity is essential for proper cell differentiation in the colon. If it is lost, it’s easy to accumulate multiple mutations through chromosomal instability <a href="https://doi.org/10.1053/j.gastro.2009.12.065">6</a>, microsatellite instability <a href="https://doi.org/10.1053/j.gastro.2009.12.064">7</a>, aberrant DNA methylation <a href="https://doi.org/10.1053/j.gastro.2006.09.018">8</a> and/or DNA repair defects leading to CRC.</p>
<p>Several altered molecular signaling pathways are involved in CRC onset, such as Wnt/APC/<span class="math inline">\(\beta\)</span>-catenin, phosphoinositide 3-kinase (PI3K)/AKT/glycogen synthase kinase-3<span class="math inline">\(\beta\)</span> (GSK-3<span class="math inline">\(\beta\)</span>), transforming growth factor-<span class="math inline">\(\beta\)</span> (TGF)-<span class="math inline">\(\beta\)</span>/Smad, NF- κb or mismatch repair genes (MMR) <a href="https://doi.org/10.3892/or.2015.4108">9</a>.</p>
<div id="wnt-beta-catenin-pathway" class="section level3">
<h3>Wnt / <span class="math inline">\(\beta\)</span>-catenin pathway</h3>
<p>Upon secretion of Wnt ligand it binds to Frizzled (Fz) receptors. This results in the inactivation of the multifunctional kinase GSK-3<span class="math inline">\(\beta\)</span> and in the stabilisation of <span class="math inline">\(\beta\)</span>-catenin. <span class="math inline">\(\beta\)</span>-catenin is a E-cadherin cell-cell adhesion protein and transcriptional activator. If it is stabilized, it gets accumulated in the cytoplasm and is translocated into the nucleus. There it interacts with members of the lymphoid enhancer factor (LEF)/t-cell factor (TCF) and activates specific target genes. In absence of Wnt-signal, <span class="math inline">\(\beta\)</span>-catenin is degradated preventing its nuclear translocation. The ubiquination and phosphorylation of <span class="math inline">\(\beta\)</span>-catenin is controlled through casein kinase 1 (CK1) and the APC/Axin/GSK-3<span class="math inline">\(\beta\)</span>-complex.</p>
<p>Activation of the Wnt pathway through mutations in the APC gene is known to have a leading role in CRC pathogenesis. The protein product of APC is among the key components of <span class="math inline">\(\beta\)</span>-catenin destruction leading to an accumulation of <span class="math inline">\(\beta\)</span>-catenin which is then translocated to the nucleus where it mediates gene transcription through interaction with the LEF/TCF transcription factor family (LEF-1/LEF1, TCF-1/TCF7, TCF-3/TCF7L1, and TCF-4/TCF7L2) <a href="http://www.doi.org/10.4103/1477-3163.78111">10</a>. The same outcome is expected, however, less frequently, through mutations in <span class="math inline">\(\beta\)</span>-catenin and Axin2 <a href="http://www.doi.org/10.1126/science.275.5307.1787">11</a> <a href="http://dx.doi.org/10.1038/79859">12</a></p>
<p>An increased concentration of <span class="math inline">\(\beta\)</span>-catenin in the cytoplasm promotes cellular proliferation. Nuclear expression of <span class="math inline">\(\beta\)</span>-catenin can be identified immunohistochemically but is not a unique factor for CRC. However, it’s among one of the components of a diagnostic panel <a href="https://doi.org/10.3892/or.2018.6330">13</a>.</p>
<div id="wnt-singnaling-and-colon-cancer" class="section level4">
<h4>Wnt-Singnaling and Colon Cancer</h4>
<p>Wnt-signaling plays a key role in early cell fate decision in embryonic stem cells and is therefore under extensive investigation in cancer research. For example, the Wnt target gene <em>LGR5</em> is a multipotent stem cell marker in crypts. ASCL2, SOX9 and Paneth cell defensins are other examples of Wnt target genes controlling various steps in the differentiation process of stem cells.</p>
<p>In different cancer types the <span class="math inline">\(\beta\)</span>-catenin dependent pathway is differentially regulated in normal tissue compared to cancerous tissue and often shows <span class="math inline">\(\beta\)</span>-catenin stabilizing mutations <a href="https://doi.org/10.1101/gad.14.15.1837">14</a> <a href="https://doi.org/10.1126/science.275.5307.1790">15</a> resulting in enhanced Wnt-signaling. Of many upstream and downstream components of <span class="math inline">\(\beta\)</span>-catenin, APC and <span class="math inline">\(\beta\)</span>-catenin are among the ones which show crucial roles in Wnt-signaling and cancer.</p>
<p>Looking at mouse models with activated Wnt-pathway through <em>APC</em> mutations, revealed that mutations in APC alone are not sufficient for carcinogenic development. The Apc<sup>min/+</sup> mouse models showed non-invasive intestinal tumors <a href="https://dx.doi.org/10.1073%2Fpnas.94.25.13927">16</a>. For unfavorable carcinoma development an increased activation of proto-oncogenetic signaling pathways (i.e. <em>K-ras</em>) and additional mutations in <em>TGFBRII</em>, <em>SMAD4</em>, <em>TP53</em> may be necessary <a href="https://doi.org/10.1016/0092-8674(90)90186-I">17</a>.</p>
<p>Further, LEF/TCF transcription factors play a crucial role in CRC and may offer therapeutic opportunities <a href="http://www.doi.org/10.4103/1477-3163.78111">18</a>. The recruitment of <span class="math inline">\(\beta\)</span>-catenin to target genes in Wnt-signaling is depending on a <span class="math inline">\(\beta\)</span>-catenin binding domain at the N-terminus of the LEF/TCF transcription factor. At the C-terminus, a sequence-specific DNA binding domain recognize Wnt response elements in target genes. Interestingly, different LEF/TCF loci produce different protein isoforms through alternative splicing and different promotors which influence Wnt-signaling and can lead to cancer development <a href="https://dx.doi.org/10.1101%2Fcshperspect.a007906">19</a> <a href="https://doi.org/10.1038/sj.onc.1210056">20</a>. The expression pattern of LEF/TCF loci varies between normal and cancerous human colon tissue. In healthy colon cells, TCF-1 and TCF-4 are expressed and LEF-1 and TCF-3 are silent. It could be shown in mouse models, that a loss of TCF-4 depeletes stem cells and eliminates cell proliferation in the intestine <a href="https://doi.org/10.1038/1270">21</a>. TCF-1 is suggested to be a feedback repressor of TCF-4 and cooperates with APC to suppress CRC. In cancerous colon cells, TCF-1 and TCF-4 are still expressed (eventhough now as a full-length form) but also LEF-1 is produced which results in a maximal <span class="math inline">\(\beta\)</span>-catenin interaction and hence in oncogenic Wnt-signaling.</p>
</div>
<div id="short-tandem-repeats-in-wnt-pathway" class="section level4">
<h4>Short Tandem Repeats in Wnt-Pathway</h4>
<p>We could show in <a href="TODO">22</a> that TRs in proteins cluster near the termini and are involved in protein-protein interaction as well as in transcription processes and DNA-binding. As shown in the section above, Wnt-signaling and the development of CRC highly depend on processes predestined for TR involvement. Therefore, we’ll take a closer look at the LEF/TCF transcription factor. Specifically we’ll investigate if we can detect TRs with the state of the art classification method <a href="https://dx.doi.org/10.1093%2Fnar%2Fgks726">23</a> in LEF/TCF transcription factors and describe their role in the Wnt/<span class="math inline">\(\beta\)</span>-catenin pathway with respect to CRC.</p>
<p>But we not only investigate on LEF/TCF proteins, in fact we analyse proteins containing tandem repeats (TRs) which are expressed by CRC favorable and unfavorable genes <a href="https://www.proteinatlas.org/humanproteome/pathology/colorectal+cancer#colorectal%20cancerunfavourable">24</a> with a focus on the members of the Wnt/<span class="math inline">\(\beta\)</span>-catenin pathway.</p>
<!-- But we not only investigate on LEF/TCF proteins but also of *TGFBRII*, *SMAD4*, *TP53* [17][Fearon1990]. Furtheron, it is known, that different types of CRC are caused through a variety of different mutations and [Nojadeh et al.][Nojadeh2018] provides a collection of genes related to CRC: *APC*, *K-ras*, *DCC*, *P53*, *COX-2*, *BCL-2*, *MMR*-genes, *MUTYH*, *STK11/LKB1*, *MLH1*, *MSH2*, *MSH6*, *PMS2*.

[Nojadeh2018]: https://dx.doi.org/10.17179%2Fexcli2017-948
-->
</div>
</div>
</div>
</div>
<div id="methods" class="section level1">
<h1>Methods</h1>
<div id="data-sources-and-collection" class="section level2">
<h2>Data Sources and Collection</h2>
<p>All protein sequences were retrieved via the REST API from UniProt/Swiss-Prot Knowledgebase <a href="https://doi.org/10.1093/nar/gky1049">23</a> release 2019_04 for the reviewed entries of the Homo Sapiens proteome (UP000005640).</p>
<div id="protein-sequence-origin" class="section level3">
<h3>Protein Sequence Origin</h3>
<p>The names of CRC favorable and unfavorable genes were downloaded manually (Mai 2019) from the proteinatlas website <a href="https://www.proteinatlas.org/humanproteome/pathology/colorectal+cancer#colorectal%20cancerunfavourable">24</a> and saved as .tsv. The sequences of proteins which are expressed from CRC favorable and unfavorable genes, were retreived from Swiss-Prot by querying all proteins from each gene. Next, we checked the .fasta file for duplicated protein IDs, which requiered manual inspection.</p>
<p>Analogously, the protein sequences for all proteins which are related to the Wnt-pathway in Swiss-Prot were retrieved and filtered for duplicates.</p>
</div>
</div>
<div id="tandem-repeat-detection-filtering" class="section level2">
<h2>Tandem Repeat Detection &amp; Filtering</h2>
<p>For the detection and filtering of TRs, we applied the open-source Python 3 Tandem Repeat Annotation Library (TRAL) <a href="https://doi.org/10.1093/bioinformatics/btv306">25</a>. <em>De novo</em> detection of TRs in protein sequences was performed applying the detectors HHrepID, T-REKS, TRUST and XSTREAM followed by a refinement with profile Hidden Markov Models (HMM) implemented with HMMER <a href="https://doi.org/10.1093/bioinformatics/14.9.755">26</a> to capture most of the TR units and their boundaries. The TRs, were then filtered on a significance level of <span class="math inline">\(\alpha = 0.05\)</span> for a Likelyhood Ratio Test under the null hypothesis of random TR sequence evolution, a TR unit divergence of <span class="math inline">\(d_{TR_{units}} &lt; 0.1\)</span> specifying the number of substitution site dating back to the most recent TR unit ancestor, a TR unit length of <span class="math inline">\(l \leq 3\)</span> specifying the number of noninsertion sites of the TR unit and a TR unit number of <span class="math inline">\(n \geq 2.5\)</span> specifying the number of noninsertion sites in the TR-MSA divided by <span class="math inline">\(l\)</span> <a href="https://dx.doi.org/10.1093%2Fnar%2Fgks726">27</a>.</p>
<div id="processing-tral-results-for-data-mining-in-r" class="section level3">
<h3>Processing TRAL Results for Data Mining in R</h3>
<p>The detected TR characteristics and their MSA are stored for each protein in a single .tsv and binary .pickle file. For further analysis, we join the results for all proteins in one file for each group (unfavorable, favorable, Wnt-pathway) containing only proteins which have TRs.</p>
<p>The TR detection and annotation workflow is implemented in Python 3 and freely available on <a href="https://github.com/matteodelucchi/CRC_TRs.git">Github</a>. For reproduction of the reported results, change the code in order to use the provided datasets. To obtain the most recent datasets, just adapt <code>main.py</code> regarding your systems specification before sourcing.</p>
</div>
</div>
<div id="tr-characterization-in-crc-associated-proteins" class="section level2">
<h2>TR Characterization in CRC Associated Proteins</h2>
<p>To provide a reproducible framework of the TR characterization the following results including the data of the previous section is implemented as <a href="https://github.com/matteodelucchi/TRAL-Result-Analysis.git">R-package on github</a> which can be installed like a regular R-package. Sourcing the vignette <code>GeneralOverviewofTandemRepeats.Rmd</code> allows an exact reproduction of the reported results.</p>
<p>The evaluation was performed using</p>
<pre><code>#&gt; R version 3.6.0 (2019-04-26)
#&gt; Platform: x86_64-pc-linux-gnu (64-bit)
#&gt; Running under: Ubuntu 18.04.2 LTS
#&gt; 
#&gt; Matrix products: default
#&gt; BLAS:   /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.7.1
#&gt; LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.7.1
#&gt; 
#&gt; locale:
#&gt;  [1] LC_CTYPE=en_US.UTF-8       LC_NUMERIC=C              
#&gt;  [3] LC_TIME=de_CH.UTF-8        LC_COLLATE=C              
#&gt;  [5] LC_MONETARY=de_CH.UTF-8    LC_MESSAGES=en_US.UTF-8   
#&gt;  [7] LC_PAPER=de_CH.UTF-8       LC_NAME=C                 
#&gt;  [9] LC_ADDRESS=C               LC_TELEPHONE=C            
#&gt; [11] LC_MEASUREMENT=de_CH.UTF-8 LC_IDENTIFICATION=C       
#&gt; 
#&gt; attached base packages:
#&gt; [1] stats4    parallel  stats     graphics  grDevices utils     datasets 
#&gt; [8] methods   base     
#&gt; 
#&gt; other attached packages:
#&gt;  [1] TRALResultAnalysis_0.0.0.9000 RCurl_1.95-4.12              
#&gt;  [3] bitops_1.0-6                  Biostrings_2.52.0            
#&gt;  [5] XVector_0.24.0                IRanges_2.18.0               
#&gt;  [7] S4Vectors_0.22.0              BiocGenerics_0.30.0          
#&gt;  [9] ggplot2_3.1.1                 dplyr_0.8.0.1                
#&gt; 
#&gt; loaded via a namespace (and not attached):
#&gt;  [1] tidyselect_0.2.5  xfun_0.6          remotes_2.0.4    
#&gt;  [4] purrr_0.3.2       colorspace_1.4-1  usethis_1.5.0    
#&gt;  [7] htmltools_0.3.6   yaml_2.2.0        rlang_0.3.4      
#&gt; [10] pkgbuild_1.0.3    pillar_1.4.0      glue_1.3.1       
#&gt; [13] withr_2.1.2       sessioninfo_1.1.1 plyr_1.8.4       
#&gt; [16] stringr_1.4.0     zlibbioc_1.30.0   munsell_0.5.0    
#&gt; [19] commonmark_1.7    gtable_0.3.0      devtools_2.0.2   
#&gt; [22] memoise_1.1.0     evaluate_0.13     knitr_1.22       
#&gt; [25] callr_3.2.0       ps_1.3.0          Rcpp_1.0.1       
#&gt; [28] backports_1.1.4   scales_1.0.0      desc_1.2.0       
#&gt; [31] pkgload_1.0.2     fs_1.3.1          digest_0.6.18    
#&gt; [34] stringi_1.4.3     processx_3.3.1    grid_3.6.0       
#&gt; [37] rprojroot_1.3-2   cli_1.1.0         tools_3.6.0      
#&gt; [40] magrittr_1.5      lazyeval_0.2.2    tibble_2.1.1     
#&gt; [43] crayon_1.3.4      pkgconfig_2.0.2   xml2_1.2.0       
#&gt; [46] prettyunits_1.0.2 assertthat_0.2.1  rmarkdown_1.12   
#&gt; [49] roxygen2_6.1.1    rstudioapi_0.10   R6_2.4.0         
#&gt; [52] compiler_3.6.0</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">library</span>(TRALResultAnalysis)
tr_crcfavorable_path &lt;-<span class="st"> </span><span class="kw">paste0</span>(base_path, <span class="st">&quot;inst/extdata/TRs_favorable_proteins_CRC_sp.tsv&quot;</span>)
tr_crcunfavorable_path &lt;-<span class="st"> </span><span class="kw">paste0</span>(base_path, <span class="st">&quot;inst/extdata/TRs_unfavorable_proteins_CRC_sp.tsv&quot;</span>)
tr_wnt_path &lt;-<span class="st"> </span><span class="kw">paste0</span>(base_path, <span class="st">&quot;inst/extdata/TRs_Wnt_proteins_CRC_sp.tsv&quot;</span>)
dest_file_sp &lt;-<span class="st"> </span><span class="kw">paste0</span>(base_path, <span class="st">&quot;data/swissprot_human.tsv&quot;</span>)
dest_file_kin &lt;-<span class="st"> </span><span class="kw">paste0</span>(base_path, <span class="st">&quot;data/swissprot_human_kinome.tsv&quot;</span>)</code></pre></div>
<p>To get deeper insights about the proteins containing TRs, more information is added from Swiss-Prot by a left join</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">sp_url &lt;-<span class="st"> &quot;https://www.uniprot.org/uniprot/?query=organism:%22Homo%20sapiens%20(Human)%20[9606]%22%20reviewed:yes&amp;format=tab&amp;columns=id,entry%20name,reviewed,protein%20names,genes,organism,length,virus%20hosts,encodedon,database(Pfam),interactor,comment(ABSORPTION),feature(ACTIVE%20SITE),comment(ACTIVITY%20REGULATION),feature(BINDING%20SITE),feature(CALCIUM%20BIND),comment(CATALYTIC%20ACTIVITY),comment(COFACTOR),feature(DNA%20BINDING),ec,comment(FUNCTION),comment(KINETICS),feature(METAL%20BINDING),feature(NP%20BIND),comment(PATHWAY),comment(PH%20DEPENDENCE),comment(REDOX%20POTENTIAL),rhea-id,feature(SITE),comment(TEMPERATURE%20DEPENDENCE)&amp;sort=organism&quot;</span>

<span class="co"># Download the swissprot file only if it doesn't already exist.</span>
<span class="co"># Uncomment this, if you want to use the most recent available data!</span>
<span class="cf">if</span>(<span class="op">!</span><span class="kw">file.exists</span>(dest_file_sp)){
    <span class="kw">download.file</span>(sp_url, <span class="dt">destfile =</span> dest_file_sp)
}

sp_all_fav &lt;-<span class="st"> </span><span class="kw">load_swissprot</span>(dest_file_sp, tr_fav)
sp_all_unfav &lt;-<span class="st"> </span><span class="kw">load_swissprot</span>(dest_file_sp, tr_unfav)
sp_all_wnt &lt;-<span class="st"> </span><span class="kw">load_swissprot</span>(dest_file_sp, tr_wnt)

tr_unfav_sp &lt;-<span class="st"> </span><span class="kw">merge</span>(<span class="dt">x =</span> tr_unfav, <span class="dt">y =</span> sp_all_unfav, <span class="dt">by =</span> <span class="st">&quot;ID&quot;</span>, <span class="dt">all.x =</span> <span class="ot">TRUE</span>)
tr_fav_sp &lt;-<span class="st"> </span><span class="kw">merge</span>(<span class="dt">x =</span> tr_fav, <span class="dt">y =</span> sp_all_fav, <span class="dt">by =</span> <span class="st">&quot;ID&quot;</span>, <span class="dt">all.x =</span> <span class="ot">TRUE</span>)
tr_wnt_sp &lt;-<span class="st"> </span><span class="kw">merge</span>(<span class="dt">x =</span> tr_wnt, <span class="dt">y =</span> sp_all_wnt, <span class="dt">by =</span> <span class="st">&quot;ID&quot;</span>, <span class="dt">all.x =</span> <span class="ot">TRUE</span>)</code></pre></div>
</div>
</div>
<div id="results-discussion" class="section level1">
<h1>Results &amp; Discussion</h1>
<p>In 243 genes associated with unfavorable CRC expressing 286 proteins we could <em>de novo</em> detect 617 TRs of which after filtering and clustering 100 TRs remained. In CRC favorable genes (352) 403 proteins are expressed, where we could <em>de novo</em> detect 486 TRs with 48 TRs beeing left after filtering and clustering.</p>
<p>Additionally, 644 proteins were associated in Swiss-Prot with the Wnt-pathway, where we could <em>de novo</em> detect 1353 TRs of which 192 TRs remained after filtering and clustering.</p>
<div id="more-trs-were-detected-in-proteins-associated-with-unfavorable-crc-prognosis" class="section level2">
<h2>More TRs Were Detected in Proteins Associated With Unfavorable CRC Prognosis</h2>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># CRC favorable</span>
<span class="kw">length</span>(<span class="kw">unique</span>(tr_fav_sp<span class="op">$</span>ID))<span class="op">/</span><span class="dv">403</span> <span class="co"># through unique() we ensure to count those proteins with &gt;1 TR only once.</span>
<span class="co">#&gt; [1] 0.0942928</span>

<span class="co"># CRC unfavorable</span>
<span class="kw">length</span>(<span class="kw">unique</span>(tr_unfav_sp<span class="op">$</span>ID))<span class="op">/</span><span class="dv">286</span> 
<span class="co">#&gt; [1] 0.2237762</span>

<span class="co"># Wnt pathway</span>
<span class="kw">length</span>(<span class="kw">unique</span>(tr_wnt_sp<span class="op">$</span>ID))
<span class="co">#&gt; [1] 138</span>
<span class="kw">length</span>(<span class="kw">unique</span>(tr_wnt_sp<span class="op">$</span>ID))<span class="op">/</span><span class="dv">644</span> 
<span class="co">#&gt; [1] 0.2142857</span></code></pre></div>
<p>Of all proteins expressed by genes associated for beeing favorable or unfavorable for CRC, 9.4% and 22.4% contain at least one TR respectively. Analogously, we could detect TRs in 138 (21.4%) of the 644 proteins involved in the Human Wnt-pathway.</p>
</div>
<div id="homo-tr-cluster-towards-the-n-terminus" class="section level2">
<h2>Homo-TR Cluster Towards the N-Terminus</h2>
<p>TRs generally cluster to the flanks of proteins with a tendency of domain-TRs to cluster near the N-terminus <a href="TODO" class="uri">TODO</a>.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">TR_location</span>(
  <span class="kw">rbind</span>(tr_fav_sp, tr_unfav_sp),
  <span class="dt">byTRtype =</span> <span class="ot">TRUE</span>)</code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<p>In proteins expressed from CRC favorable and unfavorable genes, homo-TRs show a tendency for N-terminal location. Many of the homo-TR fall in the region allocated to signal sequences which tags the proteins for extracellular translocation through the cell membrane.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">TR_location</span>(tr_fav_sp, <span class="dt">byTRtype =</span> <span class="ot">TRUE</span>)</code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">TR_location</span>(tr_unfav_sp, <span class="dt">byTRtype =</span> <span class="ot">TRUE</span>)</code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<p>Looking seperately at CRC favorable and unfavorable proteins it can be observed that favorable CRC proteins have a greater tendecy for N-terminal location of their homo-TRs. Which allows to hypothesize, that favorable CRC proteins may have a signal sequence and play extracellular roles more frequently than CRC unfavorable proteins.</p>
<p>It could be shown <a href="https://doi.org/10.1111/j.1742-4658.2010.07720.x">TODO</a> that N-terminal signal peptides are rich in Leucine residues.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># combine all TR from the three groups</span>
tr_all &lt;-<span class="st"> </span><span class="kw">rbind</span>(tr_fav, tr_unfav, tr_wnt)

AAfreq_all &lt;-<span class="st"> </span><span class="kw">AAfreq_in_TR</span>(tr_all) 
AAfreq_all[base<span class="op">::</span><span class="kw">order</span>(AAfreq_all<span class="op">$</span>aa_ratio, <span class="dt">decreasing =</span> <span class="ot">TRUE</span>),]
<span class="co">#&gt;   aa_freq aa aa_ratio</span>
<span class="co">#&gt; A     489  A   0.1750</span>
<span class="co">#&gt; S     436  S   0.1560</span>
<span class="co">#&gt; P     348  P   0.1245</span>
<span class="co">#&gt; E     347  E   0.1242</span>
<span class="co">#&gt; G     285  G   0.1020</span>
<span class="co">#&gt; Q     266  Q   0.0952</span>
<span class="co">#&gt; L     197  L   0.0705</span>
<span class="co">#&gt; R     112  R   0.0401</span>
<span class="co">#&gt; K      86  K   0.0308</span>
<span class="co">#&gt; H      66  H   0.0236</span>
<span class="co">#&gt; T      62  T   0.0222</span>
<span class="co">#&gt; D      57  D   0.0204</span>
<span class="co">#&gt; C       9  C   0.0032</span>
<span class="co">#&gt; N       8  N   0.0029</span>
<span class="co">#&gt; F       7  F   0.0025</span>
<span class="co">#&gt; V       7  V   0.0025</span>
<span class="co">#&gt; Y       5  Y   0.0018</span>
<span class="co">#&gt; I       3  I   0.0011</span>
<span class="co">#&gt; M       3  M   0.0011</span>
<span class="co">#&gt; -       2  -   0.0007</span>
<span class="co">#&gt; W       0  W   0.0000</span>
<span class="co">#&gt; U       0  U   0.0000</span>
<span class="co">#&gt; O       0  O   0.0000</span>
<span class="co">#&gt; B       0  B   0.0000</span>
<span class="co">#&gt; J       0  J   0.0000</span>
<span class="co">#&gt; Z       0  Z   0.0000</span>
<span class="co">#&gt; X       0  X   0.0000</span>
<span class="co">#&gt; *       0  *   0.0000</span>
<span class="co">#&gt; +       0  +   0.0000</span>
<span class="co">#&gt; .       0  .   0.0000</span>

AAfreq_all_homo &lt;-<span class="st"> </span><span class="kw">AAfreq_in_TR</span>(tr_all[<span class="kw">which</span>(tr_all<span class="op">$</span>l_type <span class="op">==</span><span class="st"> &quot;homo&quot;</span>),]) 
AAfreq_all_homo[base<span class="op">::</span><span class="kw">order</span>(AAfreq_all_homo<span class="op">$</span>aa_ratio, <span class="dt">decreasing =</span> <span class="ot">TRUE</span>),]
<span class="co">#&gt;   aa_freq aa aa_ratio</span>
<span class="co">#&gt; A     390  A   0.1821</span>
<span class="co">#&gt; S     342  S   0.1597</span>
<span class="co">#&gt; E     319  E   0.1489</span>
<span class="co">#&gt; Q     255  Q   0.1190</span>
<span class="co">#&gt; P     232  P   0.1083</span>
<span class="co">#&gt; G     199  G   0.0929</span>
<span class="co">#&gt; L     167  L   0.0780</span>
<span class="co">#&gt; K      71  K   0.0331</span>
<span class="co">#&gt; H      58  H   0.0271</span>
<span class="co">#&gt; T      37  T   0.0173</span>
<span class="co">#&gt; D      35  D   0.0163</span>
<span class="co">#&gt; R      27  R   0.0126</span>
<span class="co">#&gt; C       6  C   0.0028</span>
<span class="co">#&gt; Y       2  Y   0.0009</span>
<span class="co">#&gt; N       1  N   0.0005</span>
<span class="co">#&gt; F       1  F   0.0005</span>
<span class="co">#&gt; I       0  I   0.0000</span>
<span class="co">#&gt; M       0  M   0.0000</span>
<span class="co">#&gt; W       0  W   0.0000</span>
<span class="co">#&gt; V       0  V   0.0000</span>
<span class="co">#&gt; U       0  U   0.0000</span>
<span class="co">#&gt; O       0  O   0.0000</span>
<span class="co">#&gt; B       0  B   0.0000</span>
<span class="co">#&gt; J       0  J   0.0000</span>
<span class="co">#&gt; Z       0  Z   0.0000</span>
<span class="co">#&gt; X       0  X   0.0000</span>
<span class="co">#&gt; *       0  *   0.0000</span>
<span class="co">#&gt; -       0  -   0.0000</span>
<span class="co">#&gt; +       0  +   0.0000</span>
<span class="co">#&gt; .       0  .   0.0000</span>

AAfreq_all[<span class="kw">which</span>(AAfreq_all<span class="op">$</span>aa <span class="op">==</span><span class="st"> &quot;L&quot;</span>),]
<span class="co">#&gt;   aa_freq aa aa_ratio</span>
<span class="co">#&gt; L     197  L   0.0705</span>
AAfreq_all_homo[<span class="kw">which</span>(AAfreq_all_homo<span class="op">$</span>aa <span class="op">==</span><span class="st"> &quot;L&quot;</span>),]
<span class="co">#&gt;   aa_freq aa aa_ratio</span>
<span class="co">#&gt; L     167  L    0.078</span></code></pre></div>
<p>We combine all datasets and count the amino acid frequency and compare it to the amino acid frequency in homo-TRs which doesn’t show much difference for Lysine. However, we can see, that Alanine is most frequent (17.5%) followed by Serine (15.6%) in CRC and Wnt-/<span class="math inline">\(\beta\)</span>-catenin pathway associated proteins.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># (AAfreq_fav &lt;- AAfreq_in_TR(tr_fav))</span>
<span class="co"># (AAfreq_unfav &lt;- AAfreq_in_TR(tr_unfav))</span>
<span class="co"># cor.test(AAfreq_fav$aa_ratio, AAfreq_unfav$aa_ratio, method = &quot;spearman&quot;)</span></code></pre></div>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">AAratio_vs_Disorderpropensity</span>(tr_all, <span class="dt">plot_title =</span> <span class="st">&quot;CRC &amp; Wnt-Pathway Associated Proteins&quot;</span>)</code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<p>Plotting the amino acid frequency ratio of TRs in CRC and Wnt-/<span class="math inline">\(\beta\)</span>-catenin pathway associated proteins against the amino acid disorderpropensity we can see that almost only amino acids with high disorder propensity are part of TR in CRC and Wnt-/<span class="math inline">\(\beta\)</span>-catenin pathway associated proteins. With exception of Lysine and Histidine.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">AAratio_vs_Disorderpropensity</span>(<span class="dt">sp_overall =</span> <span class="ot">TRUE</span>)</code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<p>This trend is consistent with the overall amino acid frequency of all known proteins - amino acids with higher disorderpropensity appear in TRs significantly more frequent.</p>
</div>
<div id="only-few-wnt-pathway-proteins-are-associated-with-crc." class="section level2">
<h2>Only Few Wnt-pathway Proteins Are Associated With CRC.</h2>
<p>Proteins with TRs from the Wnt-pathway seem to be distinct from the proteins retrieved by genes.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># CRC favorable proteins in Wnt pathway</span>
tr_fav_sp<span class="op">$</span>protein_name[<span class="kw">which</span>(tr_fav_sp<span class="op">$</span>ID <span class="op">%in%</span><span class="st"> </span>tr_wnt_sp<span class="op">$</span>ID)]
<span class="co">#&gt; [1] &quot;Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like)&quot;</span>
<span class="co">#&gt; [2] &quot;CXXC-type zinc finger protein 5 (CF5) (Putative MAPK-activating protein PM08) (Putative NF-kappa-B-activating protein 102) (Retinoid-inducible nuclear factor) (RINF)&quot;                                                      </span>
<span class="co">#&gt; [3] &quot;DEP domain-containing protein 1B (HBV X-transactivated gene 8 protein) (HBV XAg-transactivated protein 8)&quot;</span></code></pre></div>
<p>3 Proteins which are associated with favorable CRC prognosis are invovled in the Wnt-pathway and</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># CRC unfavorable proteins in Wnt pathway</span>
tr_unfav_sp<span class="op">$</span>protein_name[<span class="kw">which</span>(tr_unfav_sp<span class="op">$</span>ID <span class="op">%in%</span><span class="st"> </span>tr_wnt_sp<span class="op">$</span>ID)]
<span class="co">#&gt; [1] &quot;Nuclear factor of activated T-cells, cytoplasmic 4 (NF-ATc4) (NFATc4) (T-cell transcription factor NFAT3) (NF-AT3)&quot;                                                </span>
<span class="co">#&gt; [2] &quot;Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein)&quot;</span>
<span class="co">#&gt; [3] &quot;Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein)&quot;</span>
<span class="co">#&gt; [4] &quot;Leucine zipper putative tumor suppressor 2 (hLZTS2) (Protein LAPSER1)&quot;                                                                                             </span>
<span class="co">#&gt; [5] &quot;Leucine zipper putative tumor suppressor 2 (hLZTS2) (Protein LAPSER1)&quot;</span></code></pre></div>
<p>5 with unfavorable prognosis.</p>
</div>
<div id="nucleic-acid-binding-proteins-show-many-repeat-regions" class="section level2">
<h2>Nucleic Acid Binding Proteins Show Many Repeat Regions</h2>
<p>The number of detected TRs exceeds the number of analysed proteins which suggests that there are proteins with more than one TR-region.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># CRC favorable proteins</span>
<span class="kw">table</span>(<span class="kw">table</span>(tr_fav<span class="op">$</span>ID))
<span class="co">#&gt; </span>
<span class="co">#&gt;  1  2  5 </span>
<span class="co">#&gt; 31  6  1</span>

<span class="co"># CRC unfavorable proteins</span>
<span class="kw">table</span>(<span class="kw">table</span>(tr_unfav_sp<span class="op">$</span>ID))
<span class="co">#&gt; </span>
<span class="co">#&gt;  1  2  3  4  5 11 </span>
<span class="co">#&gt; 46 12  2  2  1  1</span>

<span class="co"># Wnt-pathway proteins</span>
<span class="kw">table</span>(<span class="kw">table</span>(tr_wnt_sp<span class="op">$</span>ID))
<span class="co">#&gt; </span>
<span class="co">#&gt;  1  2  3  4 </span>
<span class="co">#&gt; 99 26 11  2</span></code></pre></div>
<p>Nevertheless, most of the proteins, contain only one TR-region we detect up to 11 different TR-regions i.e. in some CRC unfavorable associated proteins.</p>
<p>In proteins associated with unfavorable CRC prognosis we found in general more proteins with <span class="math inline">\(\geq 4\)</span> TRs compared to the group of unfavorable or Wnt-pathway proteins.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">protein_id_by_number_of_TR</span>(tr_unfav_sp, <span class="dv">11</span>)
<span class="co">#&gt;      prot_id </span>
<span class="co">#&gt; [1,] &quot;Q9H7N4&quot;</span>
eleven_TRs &lt;-<span class="st"> </span>tr_unfav_sp[<span class="kw">which</span>(tr_unfav_sp<span class="op">$</span>ID <span class="op">==</span><span class="st"> </span><span class="kw">protein_id_by_number_of_TR</span>(tr_unfav_sp, <span class="dv">11</span>)[[<span class="dv">1</span>]]),]
<span class="kw">unique</span>(eleven_TRs<span class="op">$</span>protein_name)
<span class="co">#&gt; [1] &quot;Splicing factor, arginine/serine-rich 19 (SR-related C-terminal domain-associated factor 1) (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)&quot;</span>
<span class="kw">unique</span>(eleven_TRs<span class="op">$</span>prot_function)
<span class="co">#&gt; [1] &quot;FUNCTION: May function in pre-mRNA splicing. {ECO:0000250}.&quot;</span></code></pre></div>
<p>For example the splicing factor protein SFR19_HUMAN (ID: Q9H7N4) shows 11 TR-regions.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">protein_id_by_number_of_TR</span>(tr_unfav_sp, <span class="dv">5</span>)
<span class="co">#&gt;      prot_id </span>
<span class="co">#&gt; [1,] &quot;Q12948&quot;</span>
five_TRs &lt;-<span class="st"> </span>tr_unfav_sp[<span class="kw">which</span>(tr_unfav_sp<span class="op">$</span>ID <span class="op">==</span><span class="st"> </span><span class="kw">protein_id_by_number_of_TR</span>(tr_unfav_sp, <span class="dv">5</span>)[[<span class="dv">1</span>]]),]
<span class="kw">unique</span>(five_TRs<span class="op">$</span>protein_name)
<span class="co">#&gt; [1] &quot;Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3)&quot;</span>
<span class="kw">unique</span>(five_TRs<span class="op">$</span>prot_function)
<span class="co">#&gt; [1] &quot;FUNCTION: DNA-binding transcriptional factor that plays a role in a broad range of cellular and developmental processes such as eye, bones, cardiovascular, kidney and skin development (PubMed:11782474, PubMed:15299087, PubMed:15684392, PubMed:16492674, PubMed:27907090, PubMed:14506133, PubMed:14578375, PubMed:15277473, PubMed:16449236, PubMed:17210863, PubMed:19793056, PubMed:19279310, PubMed:25786029, PubMed:27804176). Acts either as a transcriptional activator or repressor (PubMed:11782474). Binds to the consensus binding site 5'-[G/C][A/T]AAA[T/C]AA[A/C]-3' in promoter of target genes (PubMed:7957066, PubMed:11782474, PubMed:12533514, PubMed:14506133, PubMed:19793056, PubMed:27804176). Upon DNA-binding, promotes DNA bending (PubMed:7957066, PubMed:14506133). Acts as a transcriptional coactivator (PubMed:26565916). Stimulates Indian hedgehog (Ihh)-induced target gene expression mediated by the transcription factor GLI2, and hence regulates endochondral ossification (By similarity). Acts also as a transcriptional coregulator by increasing DNA-binding capacity of GLI2 in breast cancer cells (PubMed:26565916). Regulates FOXO1 through binding to a conserved element, 5'-GTAAACAAA-3' in its promoter region, implicating FOXC1 as an important regulator of cell viability and resistance to oxidative stress in the eye (PubMed:17993506). Cooperates with transcription factor FOXC2 in regulating expression of genes that maintain podocyte integrity (By similarity). Promotes cell growth inhibition by stopping the cell cycle in the G1 phase through TGFB1-mediated signals (PubMed:12408963). Involved in epithelial-mesenchymal transition (EMT) induction by increasing cell proliferation, migration and invasion (PubMed:20406990, PubMed:22991501). Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). Plays a role in the gene regulatory network essential for epidermal keratinocyte terminal differentiation (PubMed:27907090). Essential developmental transcriptional factor required for mesoderm-derived tissues, such as the somites, skin, bone and cartilage. Positively regulates CXCL12 and stem cell factor expression in bone marrow mesenchymal progenitor cells, and hence plays a role in the development and maintenance of mesenchymal niches for haematopoietic stem and progenitor cells (HSPC). Plays a role in corneal transparency by preventing both blood vessel and lymphatic vessel growth during embryonic development in a VEGF-dependent manner. Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). May function as a tumor suppressor (PubMed:12408963). {ECO:0000250|UniProtKB:Q61572, ECO:0000269|PubMed:11782474, ECO:0000269|PubMed:12408963, ECO:0000269|PubMed:12533514, ECO:0000269|PubMed:14506133, ECO:0000269|PubMed:14578375, ECO:0000269|PubMed:15277473, ECO:0000269|PubMed:15299087, ECO:0000269|PubMed:15684392, ECO:0000269|PubMed:16449236, ECO:0000269|PubMed:16492674, ECO:0000269|PubMed:17210863, ECO:0000269|PubMed:17993506, ECO:0000269|PubMed:19279310, ECO:0000269|PubMed:19793056, ECO:0000269|PubMed:20406990, ECO:0000269|PubMed:22991501, ECO:0000269|PubMed:25786029, ECO:0000269|PubMed:26565916, ECO:0000269|PubMed:27804176, ECO:0000269|PubMed:27907090, ECO:0000269|PubMed:7957066}.&quot;</span></code></pre></div>
<p>And Forkhead-related transcription factor 3 (ID: Q12948) appears to have 5 TR-regions which is promoting cell growth inhibition and is involved in cell migration [TODO refrence to section below where it’s more investigated].</p>
</div>
<div id="pathogenic-tandem-repeat-types-prevail" class="section level2">
<h2>Pathogenic Tandem Repeat Types Prevail</h2>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">summary</span>(tr_fav_sp<span class="op">$</span>l_effective)
<span class="co">#&gt;    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. </span>
<span class="co">#&gt;   1.000   1.000   1.000   1.292   2.000   3.000</span>
<span class="kw">unique</span>(tr_fav_sp<span class="op">$</span>l_type)
<span class="co">#&gt; [1] &quot;homo&quot;  &quot;micro&quot;</span></code></pre></div>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">summary</span>(tr_unfav_sp<span class="op">$</span>l_effective)
<span class="co">#&gt;    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. </span>
<span class="co">#&gt;    1.00    1.00    1.00    1.36    2.00    3.00</span>
<span class="kw">unique</span>(tr_unfav_sp<span class="op">$</span>l_type)
<span class="co">#&gt; [1] &quot;homo&quot;  &quot;micro&quot;</span></code></pre></div>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">summary</span>(tr_wnt_sp<span class="op">$</span>l_effective)
<span class="co">#&gt;    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. </span>
<span class="co">#&gt;   1.000   1.000   1.000   1.245   1.000   3.000</span>
<span class="kw">unique</span>(tr_wnt_sp<span class="op">$</span>l_type)
<span class="co">#&gt; [1] &quot;homo&quot;  &quot;micro&quot;</span></code></pre></div>
<p>In all three groups of proteins we could only detect homo- and micro-TRs which are known to be disease causing.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">summary</span>(tr_fav_sp<span class="op">$</span>n_effective)
<span class="co">#&gt;    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. </span>
<span class="co">#&gt;   3.000   5.500   6.000   7.229   8.250  27.000</span>
<span class="kw">summary</span>(tr_unfav_sp<span class="op">$</span>n_effective)
<span class="co">#&gt;    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. </span>
<span class="co">#&gt;   2.667   4.000   6.000   7.037   8.250  20.000</span>
<span class="kw">summary</span>(tr_wnt_sp<span class="op">$</span>n_effective)
<span class="co">#&gt;    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. </span>
<span class="co">#&gt;   3.000   6.000   6.500   7.273   8.000  42.000</span></code></pre></div>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">summary</span>(tr_fav_sp<span class="op">$</span>total_repeat_length)
<span class="co">#&gt;    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. </span>
<span class="co">#&gt;   6.000   6.000   7.000   8.333   9.000  27.000</span>
<span class="kw">summary</span>(tr_unfav_sp<span class="op">$</span>total_repeat_length)
<span class="co">#&gt;    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. </span>
<span class="co">#&gt;    6.00    6.00    8.00    8.29    9.00   20.00</span>
<span class="kw">summary</span>(tr_wnt_sp<span class="op">$</span>total_repeat_length)
<span class="co">#&gt;    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. </span>
<span class="co">#&gt;   6.000   6.000   7.000   8.146   9.000  42.000</span></code></pre></div>
<p>All TR-regions have a mean number of repeat units of 7 units per repeat with a mean TR-region length of 8 amino acids in a range of 6 up to 27, 20 and 42 residues for CRC favorable, unfavorable and Wnt-pathway associated proteins respectively.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp<span class="op">$</span>protein_name[<span class="kw">which</span>(tr_wnt_sp<span class="op">$</span>total_repeat_length <span class="op">&gt;</span><span class="st"> </span><span class="dv">15</span>)]
<span class="co">#&gt; [1] &quot;Forkhead box protein E1 (Forkhead box protein E2) (Forkhead-related protein FKHL15) (HFKH4) (HNF-3/fork head-like protein 5) (HFKL5) (Thyroid transcription factor 2) (TTF-2)&quot;                                                                                                                                                      </span>
<span class="co">#&gt; [2] &quot;Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3)&quot;                                                                                                                                                     </span>
<span class="co">#&gt; [3] &quot;Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4)&quot;             </span>
<span class="co">#&gt; [4] &quot;La-related protein 1 (La ribonucleoprotein domain family member 1)&quot;                                                                                                                                                                                                                                                                 </span>
<span class="co">#&gt; [5] &quot;Mediator of RNA polymerase II transcription subunit 12 (Activator-recruited cofactor 240 kDa component) (ARC240) (CAG repeat protein 45) (Mediator complex subunit 12) (OPA-containing protein) (Thyroid hormone receptor-associated protein complex 230 kDa component) (Trap230) (Trinucleotide repeat-containing gene 11 protein)&quot;</span>
<span class="co">#&gt; [6] &quot;Mediator of RNA polymerase II transcription subunit 12 (Activator-recruited cofactor 240 kDa component) (ARC240) (CAG repeat protein 45) (Mediator complex subunit 12) (OPA-containing protein) (Thyroid hormone receptor-associated protein complex 230 kDa component) (Trap230) (Trinucleotide repeat-containing gene 11 protein)&quot;</span>
<span class="co">#&gt; [7] &quot;Probable E3 ubiquitin-protein ligase IRF2BPL (EC 2.3.2.27) (Enhanced at puberty protein 1) (Interferon regulatory factor 2-binding protein-like)&quot;                                                                                                                                                                                   </span>
<span class="co">#&gt; [8] &quot;WD repeat-containing protein 26 (CUL4- and DDB1-associated WDR protein 2) (Myocardial ischemic preconditioning up-regulated protein 2)&quot;</span>
<span class="kw">unique</span>(tr_wnt_sp<span class="op">$</span>prot_function[<span class="kw">which</span>(tr_wnt_sp<span class="op">$</span>total_repeat_length <span class="op">&gt;</span><span class="st"> </span><span class="dv">15</span>)])
<span class="co">#&gt; [1] &quot;FUNCTION: Transcription factor that binds consensus sites on a variety of gene promoters and activate their transcription. Involved in proper palate formation, most probably through the expression of MSX1 and TGFB3 genes which are direct targets of this transcription factor. Also implicated in thyroid gland morphogenesis. May indirectly play a role in cell growth and migration through the regulation of WNT5A expression. {ECO:0000269|PubMed:12165566, ECO:0000269|PubMed:16882747, ECO:0000269|PubMed:20094846, ECO:0000269|PubMed:20484477, ECO:0000269|PubMed:21177256, ECO:0000269|PubMed:24219130, ECO:0000269|PubMed:25381600, ECO:0000269|PubMed:9697705}.&quot;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          </span>
<span class="co">#&gt; [2] &quot;FUNCTION: Chromatin reader component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA (PubMed:20159561, PubMed:20471948, PubMed:25417107, PubMed:27105114, PubMed:27545619). Specifically recognizes and binds acylated histone H3, with a marked preference for histone H3 that is crotonylated (PubMed:25417107, PubMed:27105114, PubMed:27545619). Crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors (PubMed:25417107, PubMed:27105114, PubMed:27545619). Recognizes and binds histone H3 crotonylated at 'Lys-9' (H3K9cr), and with slightly lower affinity histone H3 crotonylated at 'Lys-18' (H3K18cr) (PubMed:27105114). Also recognizes and binds histone H3 acetylated at 'Lys-9' (H3K9ac), but with lower affinity than crotonylated histone H3 (PubMed:25417107, PubMed:27105114). In the SEC complex, MLLT3 is required to recruit the complex to crotonylated histones (PubMed:27105114, PubMed:27545619). {ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:25417107, ECO:0000269|PubMed:27105114, ECO:0000269|PubMed:27545619}.&quot;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </span>
<span class="co">#&gt; [3] &quot;FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating the calcium-dependent release of a repressor complex and the recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by SMARCA4-dependent recruitment of a phospho-RB1-HDAC repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves the release of HDAC1 and recruitment of CREBBP. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development, a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. SMARCA4/BAF190A may promote neural stem cell self-renewal/proliferation by enhancing Notch-dependent proliferative signals, while concurrently making the neural stem cell insensitive to SHH-dependent differentiating cues (By similarity). Acts as a corepressor of ZEB1 to regulate E-cadherin transcription and is required for induction of epithelial-mesenchymal transition (EMT) by ZEB1. Binds via DLX1 to enhancers located in the intergenic region between DLX5 and DLX6 and this binding is stabilized by the long non-coding RNA (lncRNA) Evf2 (By similarity). Binds to RNA in a promiscuous manner (By similarity). Binding to RNAs including lncRNA Evf2 leads to inhibition of SMARCA4 ATPase and chromatin remodeling activities (By similarity). {ECO:0000250|UniProtKB:Q3TKT4, ECO:0000269|PubMed:19571879, ECO:0000269|PubMed:20418909, ECO:0000269|PubMed:29374058, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.&quot;</span>
<span class="co">#&gt; [4] &quot;FUNCTION: RNA-binding protein that regulates the translation of specific target mRNA species downstream of the mTORC1 complex, in function of growth signals and nutrient availability (PubMed:20430826, PubMed:23711370, PubMed:24532714, PubMed:25940091, PubMed:28650797, PubMed:28673543, PubMed:29244122). Interacts on the one hand with the 3' poly-A tails that are present in all mRNA molecules, and on the other hand with the 7-methylguanosine cap structure of mRNAs containing a 5' terminal oligopyrimidine (5'TOP) motif, which is present in mRNAs encoding ribosomal proteins and several components of the translation machinery (PubMed:23711370, PubMed:25940091, PubMed:28650797, PubMed:29244122, PubMed:26206669, PubMed:28379136). The interaction with the 5' end of mRNAs containing a 5'TOP motif leads to translational repression by preventing the binding of EIF4G1 (PubMed:25940091, PubMed:28650797, PubMed:29244122, PubMed:28379136). When mTORC1 is activated, LARP1 is phosphorylated and dissociates from the 5' untranslated region (UTR) of mRNA (PubMed:25940091, PubMed:28650797). Does not prevent binding of EIF4G1 to mRNAs that lack a 5'TOP motif (PubMed:28379136). Interacts with the free 40S ribosome subunit and with ribosomes, both monosomes and polysomes (PubMed:20430826, PubMed:24532714, PubMed:25940091, PubMed:28673543). Under normal nutrient availability, interacts primarily with the 3' untranslated region (UTR) of mRNAs encoding ribosomal proteins and increases protein synthesis (PubMed:23711370, PubMed:28650797). Associates with actively translating ribosomes and stimulates translation of mRNAs containing a 5'TOP motif, thereby regulating protein synthesis, and as a consequence, cell growth and proliferation (PubMed:20430826, PubMed:24532714). Stabilizes mRNAs species with a 5'TOP motif, which is required to prevent apoptosis (PubMed:20430826, PubMed:23711370, PubMed:25940091, PubMed:28673543). {ECO:0000269|PubMed:20430826, ECO:0000269|PubMed:23711370, ECO:0000269|PubMed:24532714, ECO:0000269|PubMed:25940091, ECO:0000269|PubMed:26206669, ECO:0000269|PubMed:28379136, ECO:0000269|PubMed:28650797, ECO:0000269|PubMed:28673543, ECO:0000269|PubMed:29244122}.; FUNCTION: (Microbial infection) Positively regulates the replication of dengue virus (DENV). {ECO:0000269|PubMed:26735137}.&quot;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 </span>
<span class="co">#&gt; [5] &quot;FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. This subunit may specifically regulate transcription of targets of the Wnt signaling pathway and SHH signaling pathway. {ECO:0000269|PubMed:16565090, ECO:0000269|PubMed:16595664, ECO:0000269|PubMed:17000779}.&quot;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 </span>
<span class="co">#&gt; [6] &quot;FUNCTION: Probable E3 ubiquitin protein ligase involved in the proteasome-mediated ubiquitin-dependent degradation of target proteins (PubMed:29374064). Through the degradation of CTNNB1, functions downstream of FOXF2 to negatively regulate the Wnt signaling pathway (PubMed:29374064). Probably plays a role in the development of the central nervous system and in neuronal maintenance (Probable). Also acts as a transcriptional regulator of genes controlling female reproductive function. May play a role in gene transcription by transactivating GNRH1 promoter and repressing PENK promoter (By similarity). {ECO:0000250|UniProtKB:Q5EIC4, ECO:0000269|PubMed:29374064, ECO:0000305|PubMed:17334524, ECO:0000305|PubMed:29374064, ECO:0000305|PubMed:30057031}.&quot;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        </span>
<span class="co">#&gt; [7] &quot;FUNCTION: G-beta-like protein involved in cell signal transduction (PubMed:15378603, PubMed:19446606, PubMed:22065575, PubMed:23625927, PubMed:27098453, PubMed:26895380). Acts as a negative regulator in MAPK signaling pathway (PubMed:15378603). Functions as a scaffolding protein to promote G beta:gamma-mediated PLCB2 plasma membrane translocation and subsequent activation in leukocytes (PubMed:22065575, PubMed:23625927). Core component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1 (PubMed:29911972). Acts as a negative regulator of the canonical Wnt signaling pathway through preventing ubiquitination of beta-catenin CTNNB1 by the beta-catenin destruction complex, thus negatively regulating CTNNB1 degradation (PubMed:27098453). Serves as a scaffold to coordinate PI3K/AKT pathway-driven cell growth and migration (PubMed:26895380). Protects cells from oxidative stress-induced apoptosis via the down-regulation of AP-1 transcriptional activity as well as by inhibiting cytochrome c release from mitochondria (PubMed:19446606). Protects also cells by promoting hypoxia-mediated autophagy and mitophagy (By similarity). {ECO:0000250|UniProtKB:F1LTR1, ECO:0000269|PubMed:15378603, ECO:0000269|PubMed:19446606, ECO:0000269|PubMed:23625927, ECO:0000269|PubMed:26895380, ECO:0000269|PubMed:27098453, ECO:0000269|PubMed:29911972}.&quot;</span></code></pre></div>
<p>Wnt-pathway associated proteins with long TR-regions are generally involved in transcriptional regulation. But also others, such as the WD repeat-containing protein 26 which negatively regulated the Wnt-pathway contains long repeat regions</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_fav_sp<span class="op">$</span>protein_name[<span class="kw">which</span>(tr_fav_sp<span class="op">$</span>total_repeat_length <span class="op">&gt;</span><span class="st"> </span><span class="dv">15</span>)]
<span class="co">#&gt; [1] &quot;Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)&quot;</span>
<span class="co">#&gt; [2] &quot;Vascular endothelial zinc finger 1 (Putative transcription factor DB1) (Zinc finger protein 161)&quot;                                                                    </span>
<span class="co">#&gt; [3] &quot;BMP-2-inducible protein kinase (BIKe) (EC 2.7.11.1)&quot;</span>
<span class="kw">unique</span>(tr_fav_sp<span class="op">$</span>prot_function[<span class="kw">which</span>(tr_fav_sp<span class="op">$</span>total_repeat_length <span class="op">&gt;</span><span class="st"> </span><span class="dv">15</span>)])
<span class="co">#&gt; [1] &quot;FUNCTION: Plays a role in preventing exon skipping, ensuring the accuracy of splicing and regulating alternative splicing. Interacts with other spliceosomal components, via the RS domains, to form a bridge between the 5'- and 3'-splice site binding components, U1 snRNP and U2AF. Can stimulate binding of U1 snRNP to a 5'-splice site-containing pre-mRNA. Binds to purine-rich RNA sequences, either the octamer, 5'-RGAAGAAC-3' (r=A or G) or the decamers, AGGACAGAGC/AGGACGAAGC. Binds preferentially to the 5'-CGAGGCG-3' motif in vitro. Three copies of the octamer constitute a powerful splicing enhancer in vitro, the ASF/SF2 splicing enhancer (ASE) which can specifically activate ASE-dependent splicing. Isoform ASF-2 and isoform ASF-3 act as splicing repressors. May function as export adapter involved in mRNA nuclear export through the TAP/NXF1 pathway. {ECO:0000269|PubMed:8139654}.&quot;</span>
<span class="co">#&gt; [2] &quot;FUNCTION: Possible transcription factor. Specifically binds to the CT/GC-rich region of the interleukin-3 promoter and mediates tax transactivation of IL-3. {ECO:0000269|PubMed:8035792}.&quot;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             </span>
<span class="co">#&gt; [3] &quot;FUNCTION: May be involved in osteoblast differentiation.&quot;</span></code></pre></div>
<p>Similarly proteins associated with favorable prognosis of CRC containing long TR-regions show beside transcriptional regulatory functions also roles in regulation of alternative splicing.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_unfav_sp<span class="op">$</span>protein_name[<span class="kw">which</span>(tr_unfav_sp<span class="op">$</span>total_repeat_length <span class="op">&gt;</span><span class="st"> </span><span class="dv">15</span>)]
<span class="co">#&gt; [1] &quot;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (Atrophin-1-interacting protein 3) (AIP-3) (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) (Trinucleotide repeat-containing gene 19 protein) (WW domain-containing protein 3) (WWP3)&quot;</span>
<span class="co">#&gt; [2] &quot;Splicing factor, arginine/serine-rich 19 (SR-related C-terminal domain-associated factor 1) (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)&quot;                                                                    </span>
<span class="co">#&gt; [3] &quot;Numb-like protein (Numb-related protein) (Numb-R)&quot;</span>
<span class="kw">unique</span>(tr_unfav_sp<span class="op">$</span>prot_function[<span class="kw">which</span>(tr_unfav_sp<span class="op">$</span>total_repeat_length <span class="op">&gt;</span><span class="st"> </span><span class="dv">15</span>)])
<span class="co">#&gt; [1] &quot;FUNCTION: May play a role as scaffolding protein at cell-cell junctions. May regulate acid-induced ASIC3 currents by modulating its expression at the cell surface (By similarity). {ECO:0000250}.&quot;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                </span>
<span class="co">#&gt; [2] &quot;FUNCTION: May function in pre-mRNA splicing. {ECO:0000250}.&quot;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       </span>
<span class="co">#&gt; [3] &quot;FUNCTION: Plays a role in the process of neurogenesis. Required throughout embryonic neurogenesis to maintain neural progenitor cells, also called radial glial cells (RGCs), by allowing their daughter cells to choose progenitor over neuronal cell fate. Not required for the proliferation of neural progenitor cells before the onset of embryonic neurogenesis. Also required postnatally in the subventricular zone (SVZ) neurogenesis by regulating SVZ neuroblasts survival and ependymal wall integrity. Negative regulator of NF-kappa-B signaling pathway. The inhibition of NF-kappa-B activation is mediated at least in part, by preventing MAP3K7IP2 to interact with polyubiquitin chains of TRAF6 and RIPK1 and by stimulating the 'Lys-48'-linked polyubiquitination and degradation of TRAF6 in cortical neurons. {ECO:0000269|PubMed:18299187, ECO:0000269|PubMed:20079715}.&quot;</span></code></pre></div>
<p>Interestingly, the Numb-like protein (ID: Q9Y6R0, Numbl) contains a long (20 AA) poly-Q homo-TR. Those kind of TR are prone site for diseases caused by tandem repeat disorders (TRD). Numbl is further a negative regulator of NF-<span class="math inline">\(\kappa\)</span>-B pathway. Negative regulation of NF-<span class="math inline">\(\kappa\)</span>-B pathway is known as a source of CRC through interaction with Wnt/<span class="math inline">\(\beta\)</span>-catenin pathway. One possible interaction leading to CRC is through NF-<span class="math inline">\(\kappa\)</span>-B upregulated Lef1-expression which enhances transcriptional activity of TCF/LEF <a href="https://dx.doi.org/10.3389%2Ffimmu.2016.00378">REF</a>.</p>
</div>
<div id="binding-of-leftcf-to-beta-catenin-is-mediated-through-tandem-repeats" class="section level2">
<h2>Binding of LEF/TCF to <span class="math inline">\(\beta\)</span>-Catenin is Mediated Through Tandem Repeats</h2>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># Show only a selection of variables</span>
sel_var &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="st">&quot;ID&quot;</span>, <span class="st">&quot;begin&quot;</span>, <span class="st">&quot;msa_original&quot;</span>, <span class="st">&quot;repeat_region_length&quot;</span>, <span class="st">&quot;l_type&quot;</span>, <span class="st">&quot;prot_name&quot;</span>, <span class="st">&quot;protein_name&quot;</span>, <span class="st">&quot;gene_names&quot;</span>, <span class="st">&quot;prot_function&quot;</span>)
tr_wnt_sp[<span class="kw">which</span>(tr_wnt_sp<span class="op">$</span>ID <span class="op">==</span><span class="st"> &quot;Q9UJU2&quot;</span>),sel_var]
<span class="co">#&gt;         ID begin    msa_original repeat_region_length l_type  prot_name</span>
<span class="co">#&gt; 179 Q9UJU2     6 G,G,G,G,G,G,G,G                    8   homo LEF1_HUMAN</span>
<span class="co">#&gt;                                                                                               protein_name</span>
<span class="co">#&gt; 179 Lymphoid enhancer-binding factor 1 (LEF-1) (T cell-specific transcription factor 1-alpha) (TCF1-alpha)</span>
<span class="co">#&gt;     gene_names</span>
<span class="co">#&gt; 179       LEF1</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          prot_function</span>
<span class="co">#&gt; 179 FUNCTION: Participates in the Wnt signaling pathway. Activates transcription of target genes in the presence of CTNNB1 and EP300. May play a role in hair cell differentiation and follicle morphogenesis. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by LEF1 and CTNNB1. Regulates T-cell receptor alpha enhancer function. Binds DNA in a sequence-specific manner. PIAG antagonizes both Wnt-dependent and Wnt-independent activation by LEF1 (By similarity). Isoform 3 lacks the CTNNB1 interaction domain and may be an antagonist for Wnt signaling. Isoform 5 transcriptionally activates the fibronectin promoter, binds to and represses transcription from the E-cadherin promoter in a CTNNB1-independent manner, and is involved in reducing cellular aggregation and increasing cell migration of pancreatic cancer cells. Isoform 1 transcriptionally activates MYC and CCND1 expression and enhances proliferation of pancreatic tumor cells. {ECO:0000250, ECO:0000269|PubMed:11266540, ECO:0000269|PubMed:19653274, ECO:0000269|PubMed:2010090}.</span></code></pre></div>
<p>In LEF1 we found a significant poly-G TR-region at the N-terminal end which falls in the binding region with <span class="math inline">\(\beta\)</span>-catenin1 (positions 1-66 based on similarity <a href="https://www.uniprot.org/uniprot/Q9UJU2#family_and_domains">TODO</a>). <em>LEF1</em> has been identified as beeing only expressed in CRC cells but not in healthy colon tissue. However, it could be detected that different splicing variants in alteri result in the loss of the <span class="math inline">\(\beta\)</span>-catenin binding site which acts as a transcriptional repressor often expressed in healthy colon epithelial cells <a href="https://www.nature.com/articles/ng0501-53">TODO</a>.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">which</span>(tr_wnt_sp<span class="op">$</span>ID <span class="op">==</span><span class="st"> &quot;Q9HCS4&quot;</span>),sel_var]
<span class="co">#&gt;         ID begin        msa_original repeat_region_length l_type</span>
<span class="co">#&gt; 160 Q9HCS4     5 G,G,G,G,G,G,G,G,G,G                   10   homo</span>
<span class="co">#&gt;       prot_name</span>
<span class="co">#&gt; 160 TF7L1_HUMAN</span>
<span class="co">#&gt;                                                               protein_name</span>
<span class="co">#&gt; 160 Transcription factor 7-like 1 (HMG box transcription factor 3) (TCF-3)</span>
<span class="co">#&gt;      gene_names</span>
<span class="co">#&gt; 160 TCF7L1 TCF3</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                     prot_function</span>
<span class="co">#&gt; 160 FUNCTION: Participates in the Wnt signaling pathway. Binds to DNA and acts as a repressor in the absence of CTNNB1, and as an activator in its presence. Necessary for the terminal differentiation of epidermal cells, the formation of keratohyalin granules and the development of the barrier function of the epidermis (By similarity). Down-regulates NQO1, leading to increased mitomycin c resistance. {ECO:0000250}.</span>
tr_wnt_sp[<span class="kw">which</span>(tr_wnt_sp<span class="op">$</span>ID <span class="op">==</span><span class="st"> &quot;P36402&quot;</span>),sel_var]
<span class="co">#&gt;        ID begin msa_original repeat_region_length l_type  prot_name</span>
<span class="co">#&gt; 43 P36402    73     GA,GA,GA                    6  micro TCF7_HUMAN</span>
<span class="co">#&gt;                                                                                         protein_name</span>
<span class="co">#&gt; 43 Transcription factor 7 (TCF-7) (T-cell-specific transcription factor 1) (T-cell factor 1) (TCF-1)</span>
<span class="co">#&gt;    gene_names</span>
<span class="co">#&gt; 43  TCF7 TCF1</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           prot_function</span>
<span class="co">#&gt; 43 FUNCTION: Transcriptional activator involved in T-cell lymphocyte differentiation. Necessary for the survival of CD4(+) CD8(+) immature thymocytes. Isoforms lacking the N-terminal CTNNB1 binding domain cannot fulfill this role. Binds to the T-lymphocyte-specific enhancer element (5'-WWCAAAG-3') found in the promoter of the CD3E gene. May also act as feedback transcriptional repressor of CTNNB1 and TCF7L2 target genes. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by TCF7 and CTNNB1.</span></code></pre></div>
<p>A similar motif could be detected in TCF-3 and TCF-7 which have also a poly-G TR-region near the N-terminus offering a presumable binding region for <span class="math inline">\(\beta\)</span>-catenin1 <a href="https://doi.org/10.1016/S0065-230X(08)60783-6">TODO</a>. Through this binding region, TCF-3 can mediate <span class="math inline">\(\beta\)</span>-catenin degradation <a href="https://dx.doi.org/10.1083%2Fjcb.200102074">TODO</a>.</p>
<!-- https://doi.org/10.1002/ijc.24802 -->
</div>
<div id="beta-catenin-destruction-complex-not-only-relies-on-tandem-repeats" class="section level2">
<h2><span class="math inline">\(\beta\)</span>-Catenin Destruction Complex Not Only Relies On Tandem Repeats</h2>
<p>The <span class="math inline">\(\beta\)</span>-catenin destruction complex comprises different proteins, such as adenomatosis polyposis coli (APC), Axin, protein phosphatase (PP2A), glycogen synthase kinase 3 (GSK3) and casein kinase 1<span class="math inline">\(\alpha\)</span> (CK1<span class="math inline">\(\alpha\)</span>).</p>
<div id="apc-beta-catenin-binding-domain-contains-tandem-repeats" class="section level3">
<h3>APC <span class="math inline">\(\beta\)</span>-Catenin Binding Domain Contains Tandem Repeats</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">grepl</span>(<span class="st">&quot;APC&quot;</span>, tr_wnt_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt;        ID begin msa_original repeat_region_length l_type  prot_name</span>
<span class="co">#&gt; 27 O95996  1378     PA,PA,PA                    6  micro APCL_HUMAN</span>
<span class="co">#&gt; 28 O95996   841     AK,AK,AK                    6  micro APCL_HUMAN</span>
<span class="co">#&gt; 42 P25054  2763  S,S,S,S,S,S                    6   homo  APC_HUMAN</span>
<span class="co">#&gt;                                                                                 protein_name</span>
<span class="co">#&gt; 27 Adenomatous polyposis coli protein 2 (Adenomatous polyposis coli protein-like) (APC-like)</span>
<span class="co">#&gt; 28 Adenomatous polyposis coli protein 2 (Adenomatous polyposis coli protein-like) (APC-like)</span>
<span class="co">#&gt; 42               Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5)</span>
<span class="co">#&gt;    gene_names</span>
<span class="co">#&gt; 27  APC2 APCL</span>
<span class="co">#&gt; 28  APC2 APCL</span>
<span class="co">#&gt; 42  APC DP2.5</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       prot_function</span>
<span class="co">#&gt; 27                                                                                                                                                                                                                                                                                                                                                                                                                 FUNCTION: Stabilizes microtubules and may regulate actin fiber dynamics through the activation of Rho family GTPases (PubMed:25753423). May also function in Wnt signaling by promoting the rapid degradation of CTNNB1 (PubMed:10021369, PubMed:11691822, PubMed:9823329). {ECO:0000269|PubMed:10021369, ECO:0000269|PubMed:11691822, ECO:0000269|PubMed:25753423, ECO:0000269|PubMed:9823329}.</span>
<span class="co">#&gt; 28                                                                                                                                                                                                                                                                                                                                                                                                                 FUNCTION: Stabilizes microtubules and may regulate actin fiber dynamics through the activation of Rho family GTPases (PubMed:25753423). May also function in Wnt signaling by promoting the rapid degradation of CTNNB1 (PubMed:10021369, PubMed:11691822, PubMed:9823329). {ECO:0000269|PubMed:10021369, ECO:0000269|PubMed:11691822, ECO:0000269|PubMed:25753423, ECO:0000269|PubMed:9823329}.</span>
<span class="co">#&gt; 42 FUNCTION: Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization. {ECO:0000269|PubMed:10947987, ECO:0000269|PubMed:17599059, ECO:0000269|PubMed:19151759, ECO:0000269|PubMed:19893577, ECO:0000269|PubMed:20937854}.</span></code></pre></div>
<p>The polyS homo-TR region in the APC protein sequence was the only repeat region which could be detected, eventhough there are structurally verified armadillo repeats near the N-terminal end of the protein sequence. However, in the very similar APC-like protein, we could detect a micro-TR in a region associated with <span class="math inline">\(\beta\)</span>-catenin binding necessary for its degradation <a href="http://cancerres.aacrjournals.org/content/58/22/5176">TODO</a>.</p>
</div>
<div id="gsk" class="section level3">
<h3>GSK</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">grepl</span>(<span class="st">&quot;GSK&quot;</span>, tr_wnt_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt;        ID begin        msa_original repeat_region_length l_type</span>
<span class="co">#&gt; 46 P49840    26 G,G,G,G,G,G,G,G,G,G                   10   homo</span>
<span class="co">#&gt; 47 P49841   412            AS,AS,AS                    6  micro</span>
<span class="co">#&gt;      prot_name</span>
<span class="co">#&gt; 46 GSK3A_HUMAN</span>
<span class="co">#&gt; 47 GSK3B_HUMAN</span>
<span class="co">#&gt;                                                                                                           protein_name</span>
<span class="co">#&gt; 46 Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1)</span>
<span class="co">#&gt; 47   Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)</span>
<span class="co">#&gt;    gene_names</span>
<span class="co">#&gt; 46      GSK3A</span>
<span class="co">#&gt; 47      GSK3B</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        prot_function</span>
<span class="co">#&gt; 46                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            FUNCTION: Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), CTNNB1/beta-catenin, APC and AXIN1 (PubMed:11749387, PubMed:17478001, PubMed:19366350). Requires primed phosphorylation of the majority of its substrates (PubMed:11749387, PubMed:17478001, PubMed:19366350). Contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis (PubMed:11749387, PubMed:17478001, PubMed:19366350). Regulates glycogen metabolism in liver, but not in muscle (By similarity). May also mediate the development of insulin resistance by regulating activation of transcription factors (PubMed:10868943, PubMed:17478001). In Wnt signaling, regulates the level and transcriptional activity of nuclear CTNNB1/beta-catenin (PubMed:17229088). Facilitates amyloid precursor protein (APP) processing and the generation of APP-derived amyloid plaques found in Alzheimer disease (PubMed:12761548). May be involved in the regulation of replication in pancreatic beta-cells (By similarity). Is necessary for the establishment of neuronal polarity and axon outgrowth (By similarity). Through phosphorylation of the anti-apoptotic protein MCL1, may control cell apoptosis in response to growth factors deprivation (By similarity). Acts as a regulator of autophagy by mediating phosphorylation of KAT5/TIP60 under starvation conditions, leading to activate KAT5/TIP60 acetyltransferase activity and promote acetylation of key autophagy regulators, such as ULK1 and RUBCNL/Pacer (PubMed:30704899). {ECO:0000250|UniProtKB:P18265, ECO:0000250|UniProtKB:Q2NL51, ECO:0000269|PubMed:10868943, ECO:0000269|PubMed:12761548, ECO:0000269|PubMed:17229088, ECO:0000269|PubMed:30704899, ECO:0000303|PubMed:11749387, ECO:0000303|PubMed:17478001, ECO:0000303|PubMed:19366350}.</span>
<span class="co">#&gt; 47 FUNCTION: Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. MAPT/TAU is the principal component of neurofibrillary tangles in Alzheimer disease. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells and diabetes. Through phosphorylation of the anti-apoptotic protein MCL1, may control cell apoptosis in response to growth factors deprivation. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Phosphorylates ZC3HAV1 which enhances its antiviral activity. Phosphorylates SNAI1, leading to its BTRC-triggered ubiquitination and proteasomal degradation. Phosphorylates SFPQ at 'Thr-687' upon T-cell activation. Phosphorylates NR1D1 st 'Ser-55' and 'Ser-59' and stabilizes it by protecting it from proteasomal degradation. Regulates the circadian clock via phosphorylation of the major clock components including ARNTL/BMAL1, CLOCK and PER2 (PubMed:19946213, PubMed:28903391). Phosphorylates CLOCK AT 'Ser-427' and targets it for proteasomal degradation (PubMed:19946213). Phosphorylates ARNTL/BMAL1 at 'Ser-17' and 'Ser-21' and primes it for ubiquitination and proteasomal degradation (PubMed:28903391). Phosphorylates OGT at 'Ser-3' or 'Ser-4' which positively regulates its activity. Phosphorylates MYCN in neuroblastoma cells which may promote its degradation (PubMed:24391509). Regulates the circadian rhythmicity of hippocampal long-term potentiation and ARNTL/BMLA1 and PER2 expression (By similarity). Acts as a regulator of autophagy by mediating phosphorylation of KAT5/TIP60 under starvation conditions, leading to activate KAT5/TIP60 acetyltransferase activity and promote acetylation of key autophagy regulators, such as ULK1 and RUBCNL/Pacer (PubMed:30704899). {ECO:0000250|UniProtKB:Q9WV60, ECO:0000269|PubMed:11430833, ECO:0000269|PubMed:12554650, ECO:0000269|PubMed:14690523, ECO:0000269|PubMed:15448698, ECO:0000269|PubMed:15647282, ECO:0000269|PubMed:16484495, ECO:0000269|PubMed:18348280, ECO:0000269|PubMed:1846781, ECO:0000269|PubMed:19946213, ECO:0000269|PubMed:20932480, ECO:0000269|PubMed:20937854, ECO:0000269|PubMed:22514281, ECO:0000269|PubMed:24391509, ECO:0000269|PubMed:28903391, ECO:0000269|PubMed:30704899, ECO:0000269|PubMed:8397507, ECO:0000269|PubMed:9072970, ECO:0000269|PubMed:9819408}.</span></code></pre></div>
<p>In GSK3A and GSK3B we could detect a polyG homo-TR at N-terminal proximity and a micro TR near the C-terminus respectively.</p>
</div>
<div id="casein-kinase-i" class="section level3">
<h3>Casein Kinase I</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">grepl</span>(<span class="st">&quot;KC&quot;</span>, tr_wnt_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt; [1] ID                   begin                msa_original        </span>
<span class="co">#&gt; [4] repeat_region_length l_type               prot_name           </span>
<span class="co">#&gt; [7] protein_name         gene_names           prot_function       </span>
<span class="co">#&gt; &lt;0 rows&gt; (or 0-length row.names)</span>
tr_fav_sp[<span class="kw">grepl</span>(<span class="st">&quot;KC&quot;</span>, tr_fav_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt; [1] ID                   begin                msa_original        </span>
<span class="co">#&gt; [4] repeat_region_length l_type               prot_name           </span>
<span class="co">#&gt; [7] protein_name         gene_names           prot_function       </span>
<span class="co">#&gt; &lt;0 rows&gt; (or 0-length row.names)</span>
tr_unfav_sp[<span class="kw">grepl</span>(<span class="st">&quot;KC&quot;</span>, tr_unfav_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt; [1] ID                   begin                msa_original        </span>
<span class="co">#&gt; [4] repeat_region_length l_type               prot_name           </span>
<span class="co">#&gt; [7] protein_name         gene_names           prot_function       </span>
<span class="co">#&gt; &lt;0 rows&gt; (or 0-length row.names)</span></code></pre></div>
<p>With the applied filtering approach, no TRs were found in any Casein kinase I isoform epsilon. Neither in the Wnt-pathway protein set nor in the CRC favorable or unfavorable set.</p>
</div>
<div id="axin-offers-a-prone-site-for-tandem-repeat-disorder" class="section level3">
<h3>Axin Offers A Prone Site For Tandem Repeat Disorder</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">grepl</span>(<span class="st">&quot;AXIN&quot;</span>, tr_wnt_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt;         ID begin msa_original repeat_region_length l_type   prot_name</span>
<span class="co">#&gt; 189 Q9Y2T1   469  H,H,H,H,H,H                    6   homo AXIN2_HUMAN</span>
<span class="co">#&gt;                                                                  protein_name</span>
<span class="co">#&gt; 189 Axin-2 (Axin-like protein) (Axil) (Axis inhibition protein 2) (Conductin)</span>
<span class="co">#&gt;     gene_names</span>
<span class="co">#&gt; 189      AXIN2</span>
<span class="co">#&gt;                                                                                                                                                                                prot_function</span>
<span class="co">#&gt; 189 FUNCTION: Inhibitor of the Wnt signaling pathway. Down-regulates beta-catenin. Probably facilitate the phosphorylation of beta-catenin and APC by GSK3B. {ECO:0000250|UniProtKB:O15169}.</span></code></pre></div>
<p>Mutations in AXIN1 and AXIN2 are involved with CRC pathogenesis <a href="http://dx.doi.org/10.1038/79859">TODO</a>. In Axin-2 overlapping with the compositionally biased histidine region, a polyH homo-TR could be detected which falls in the region interacting with armadillo repeats in <span class="math inline">\(\beta\)</span>-catenin.</p>
<p>TRD in this region may destabilize the binding of <span class="math inline">\(\beta\)</span>-catenin to the protein-complex with Axin-2 resulting in a accumulation of <span class="math inline">\(\beta\)</span>-catenin followed by a transcriptional activation of the Wnt/<span class="math inline">\(\beta\)</span>-catenin target genes which is known to be a leading cause CRC.</p>
</div>
</div>
<div id="dishevelled-proteins" class="section level2">
<h2>Dishevelled Proteins</h2>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">grepl</span>(<span class="st">&quot;DVL&quot;</span>, tr_wnt_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt;       ID begin msa_original repeat_region_length l_type  prot_name</span>
<span class="co">#&gt; 4 O14641   686  P,P,P,P,P,P                    6   homo DVL2_HUMAN</span>
<span class="co">#&gt;                                                                         protein_name</span>
<span class="co">#&gt; 4 Segment polarity protein dishevelled homolog DVL-2 (Dishevelled-2) (DSH homolog 2)</span>
<span class="co">#&gt;   gene_names</span>
<span class="co">#&gt; 4       DVL2</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                           prot_function</span>
<span class="co">#&gt; 4 FUNCTION: Plays a role in the signal transduction pathways mediated by multiple Wnt genes. Participates both in canonical and non-canonical Wnt signaling by binding to the cytoplasmic C-terminus of frizzled family members and transducing the Wnt signal to down-stream effectors. Promotes internalization and degradation of frizzled proteins upon Wnt signaling. {ECO:0000250|UniProtKB:Q60838, ECO:0000269|PubMed:19252499}.</span></code></pre></div>
<p>Dishevelled proteins bind to the C-terminus of frizzeled proteins promoting their internalisation upon Wnt-signaling <a href="http://dx.doi.org/10.1038/nchembio.152">TODO</a>. DVL-2 shows a polyP homo-TR near it’s C-terminal end which could to our knowledge not be brought in contribution with Frizzled-binding.</p>
<p>FOXK1 and FOXK2 are positively transcriptionally regulating the Wnt-pathway and interact with DVL proteins. FOXK1/2 are reported to be highly expressed in CRC and correlate with nuclear localisation of DVL proteins <a href="https://doi.org/10.1016/j.devcel.2015.01.031">TODO</a>.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">grepl</span>(<span class="st">&quot;FOX&quot;</span>, tr_wnt_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt;        ID begin                    msa_original repeat_region_length</span>
<span class="co">#&gt; 2  O00358   164 A,A,A,A,A,A,A,A,A,A,A,A,A,A,A,A                   16</span>
<span class="co">#&gt; 57 P85037    27                   A,A,A,A,A,A,A                    7</span>
<span class="co">#&gt; 58 P85037   690                        AS,AS,AS                    6</span>
<span class="co">#&gt; 59 Q01167     2                     A,A,A,A,A,A                    6</span>
<span class="co">#&gt; 60 Q01167   608                        AS,AS,AS                    6</span>
<span class="co">#&gt;    l_type   prot_name</span>
<span class="co">#&gt; 2    homo FOXE1_HUMAN</span>
<span class="co">#&gt; 57   homo FOXK1_HUMAN</span>
<span class="co">#&gt; 58  micro FOXK1_HUMAN</span>
<span class="co">#&gt; 59   homo FOXK2_HUMAN</span>
<span class="co">#&gt; 60  micro FOXK2_HUMAN</span>
<span class="co">#&gt;                                                                                                                                                                     protein_name</span>
<span class="co">#&gt; 2  Forkhead box protein E1 (Forkhead box protein E2) (Forkhead-related protein FKHL15) (HFKH4) (HNF-3/fork head-like protein 5) (HFKL5) (Thyroid transcription factor 2) (TTF-2)</span>
<span class="co">#&gt; 57                                                                                                                        Forkhead box protein K1 (Myocyte nuclear factor) (MNF)</span>
<span class="co">#&gt; 58                                                                                                                        Forkhead box protein K1 (Myocyte nuclear factor) (MNF)</span>
<span class="co">#&gt; 59                                                               Forkhead box protein K2 (G/T-mismatch specific binding protein) (nGTBP) (Interleukin enhancer-binding factor 1)</span>
<span class="co">#&gt; 60                                                               Forkhead box protein K2 (G/T-mismatch specific binding protein) (nGTBP) (Interleukin enhancer-binding factor 1)</span>
<span class="co">#&gt;                       gene_names</span>
<span class="co">#&gt; 2  FOXE1 FKHL15 FOXE2 TITF2 TTF2</span>
<span class="co">#&gt; 57                     FOXK1 MNF</span>
<span class="co">#&gt; 58                     FOXK1 MNF</span>
<span class="co">#&gt; 59                FOXK2 ILF ILF1</span>
<span class="co">#&gt; 60                FOXK2 ILF ILF1</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              prot_function</span>
<span class="co">#&gt; 2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         FUNCTION: Transcription factor that binds consensus sites on a variety of gene promoters and activate their transcription. Involved in proper palate formation, most probably through the expression of MSX1 and TGFB3 genes which are direct targets of this transcription factor. Also implicated in thyroid gland morphogenesis. May indirectly play a role in cell growth and migration through the regulation of WNT5A expression. {ECO:0000269|PubMed:12165566, ECO:0000269|PubMed:16882747, ECO:0000269|PubMed:20094846, ECO:0000269|PubMed:20484477, ECO:0000269|PubMed:21177256, ECO:0000269|PubMed:24219130, ECO:0000269|PubMed:25381600, ECO:0000269|PubMed:9697705}.</span>
<span class="co">#&gt; 57 FUNCTION: Transcriptional regulator involved in different processes such as glucose metabolism, aerobic glycolysis, muscle cell differentiation and autophagy (By similarity). Recognizes and binds the forkhead DNA sequence motif (5'-GTAAACA-3') and can both act as a transcription activator or repressor, depending on the context (PubMed:17670796). Together with FOXK2, acts as a key regulator of metabolic reprogramming towards aerobic glycolysis, a process in which glucose is converted to lactate in the presence of oxygen (By similarity). Acts by promoting expression of enzymes for glycolysis (such as hexokinase-2 (HK2), phosphofructokinase, pyruvate kinase (PKLR) and lactate dehydrogenase), while suppressing further oxidation of pyruvate in the mitochondria by up-regulating pyruvate dehydrogenase kinases PDK1 and PDK4 (By similarity). Probably plays a role in gluconeogenesis during overnight fasting, when lactate from white adipose tissue and muscle is the main substrate (By similarity). Involved in mTORC1-mediated metabolic reprogramming: in response to mTORC1 signaling, translocates into the nucleus and regulates the expression of genes associated with glycolysis and downstream anabolic pathways, such as HIF1A, thereby regulating glucose metabolism (By similarity). Together with FOXK2, acts as a negative regulator of autophagy in skeletal muscle: in response to starvation, enters the nucleus, binds the promoters of autophagy genes and represses their expression, preventing proteolysis of skeletal muscle proteins (By similarity). Acts as a transcriptional regulator of the myogenic progenitor cell population in skeletal muscle (By similarity). Binds to the upstream enhancer region (CCAC box) of myoglobin (MB) gene, regulating the myogenic progenitor cell population (By similarity). Promotes muscle progenitor cell proliferation by repressing the transcriptional activity of FOXO4, thereby inhibiting myogenic differentiation (By similarity). Involved in remodeling processes of adult muscles that occur in response to physiological stimuli (By similarity). Required to correct temporal orchestration of molecular and cellular events necessary for muscle repair (By similarity). Represses myogenic differentiation by inhibiting MEFC activity (By similarity). Positively regulates Wnt/beta-catenin signaling by translocating DVL into the nucleus (PubMed:25805136). Reduces virus replication, probably by binding the interferon stimulated response element (ISRE) to promote antiviral gene expression (PubMed:25852164). {ECO:0000250|UniProtKB:P42128, ECO:0000269|PubMed:17670796, ECO:0000269|PubMed:25805136, ECO:0000269|PubMed:25852164}.</span>
<span class="co">#&gt; 58 FUNCTION: Transcriptional regulator involved in different processes such as glucose metabolism, aerobic glycolysis, muscle cell differentiation and autophagy (By similarity). Recognizes and binds the forkhead DNA sequence motif (5'-GTAAACA-3') and can both act as a transcription activator or repressor, depending on the context (PubMed:17670796). Together with FOXK2, acts as a key regulator of metabolic reprogramming towards aerobic glycolysis, a process in which glucose is converted to lactate in the presence of oxygen (By similarity). Acts by promoting expression of enzymes for glycolysis (such as hexokinase-2 (HK2), phosphofructokinase, pyruvate kinase (PKLR) and lactate dehydrogenase), while suppressing further oxidation of pyruvate in the mitochondria by up-regulating pyruvate dehydrogenase kinases PDK1 and PDK4 (By similarity). Probably plays a role in gluconeogenesis during overnight fasting, when lactate from white adipose tissue and muscle is the main substrate (By similarity). Involved in mTORC1-mediated metabolic reprogramming: in response to mTORC1 signaling, translocates into the nucleus and regulates the expression of genes associated with glycolysis and downstream anabolic pathways, such as HIF1A, thereby regulating glucose metabolism (By similarity). Together with FOXK2, acts as a negative regulator of autophagy in skeletal muscle: in response to starvation, enters the nucleus, binds the promoters of autophagy genes and represses their expression, preventing proteolysis of skeletal muscle proteins (By similarity). Acts as a transcriptional regulator of the myogenic progenitor cell population in skeletal muscle (By similarity). Binds to the upstream enhancer region (CCAC box) of myoglobin (MB) gene, regulating the myogenic progenitor cell population (By similarity). Promotes muscle progenitor cell proliferation by repressing the transcriptional activity of FOXO4, thereby inhibiting myogenic differentiation (By similarity). Involved in remodeling processes of adult muscles that occur in response to physiological stimuli (By similarity). Required to correct temporal orchestration of molecular and cellular events necessary for muscle repair (By similarity). Represses myogenic differentiation by inhibiting MEFC activity (By similarity). Positively regulates Wnt/beta-catenin signaling by translocating DVL into the nucleus (PubMed:25805136). Reduces virus replication, probably by binding the interferon stimulated response element (ISRE) to promote antiviral gene expression (PubMed:25852164). {ECO:0000250|UniProtKB:P42128, ECO:0000269|PubMed:17670796, ECO:0000269|PubMed:25805136, ECO:0000269|PubMed:25852164}.</span>
<span class="co">#&gt; 59                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   FUNCTION: Transcriptional regulator involved in different processes such as glucose metabolism, aerobic glycolysis and autophagy (By similarity). Recognizes and binds the forkhead DNA sequence motif (5'-GTAAACA-3') and can both act as a transcription activator or repressor, depending on the context (PubMed:22083952, PubMed:25451922). Together with FOXK1, acts as a key regulator of metabolic reprogramming towards aerobic glycolysis, a process in which glucose is converted to lactate in the presence of oxygen (By similarity). Acts by promoting expression of enzymes for glycolysis (such as hexokinase-2 (HK2), phosphofructokinase, pyruvate kinase (PKLR) and lactate dehydrogenase), while suppressing further oxidation of pyruvate in the mitochondria by up-regulating pyruvate dehydrogenase kinases PDK1 and PDK4 (By similarity). Probably plays a role in gluconeogenesis during overnight fasting, when lactate from white adipose tissue and muscle is the main substrate (By similarity). Together with FOXK1, acts as a negative regulator of autophagy in skeletal muscle: in response to starvation, enters the nucleus, binds the promoters of autophagy genes and represses their expression, preventing proteolysis of skeletal muscle proteins (By similarity). In addition to the 5'-GTAAACA-3' DNA motif, also binds the 5'-TGANTCA-3' palindromic DNA motif, and co-associates with JUN/AP-1 to activate transcription (PubMed:22083952). Also able to bind to a minimal DNA heteroduplex containing a G/T-mismatch with 5'-TRT[G/T]NB-3' sequence (PubMed:20097901). Binds to NFAT-like motifs (purine-rich) in the IL2 promoter (PubMed:1339390). Positively regulates WNT/beta-catenin signaling by translocating DVL proteins into the nucleus (PubMed:25805136). Also binds to HIV-1 long terminal repeat. May be involved in both positive and negative regulation of important viral and cellular promoter elements (PubMed:1909027). {ECO:0000250|UniProtKB:Q3UCQ1, ECO:0000269|PubMed:1339390, ECO:0000269|PubMed:1909027, ECO:0000269|PubMed:20097901, ECO:0000269|PubMed:22083952, ECO:0000269|PubMed:25451922, ECO:0000269|PubMed:25805136}.</span>
<span class="co">#&gt; 60                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   FUNCTION: Transcriptional regulator involved in different processes such as glucose metabolism, aerobic glycolysis and autophagy (By similarity). Recognizes and binds the forkhead DNA sequence motif (5'-GTAAACA-3') and can both act as a transcription activator or repressor, depending on the context (PubMed:22083952, PubMed:25451922). Together with FOXK1, acts as a key regulator of metabolic reprogramming towards aerobic glycolysis, a process in which glucose is converted to lactate in the presence of oxygen (By similarity). Acts by promoting expression of enzymes for glycolysis (such as hexokinase-2 (HK2), phosphofructokinase, pyruvate kinase (PKLR) and lactate dehydrogenase), while suppressing further oxidation of pyruvate in the mitochondria by up-regulating pyruvate dehydrogenase kinases PDK1 and PDK4 (By similarity). Probably plays a role in gluconeogenesis during overnight fasting, when lactate from white adipose tissue and muscle is the main substrate (By similarity). Together with FOXK1, acts as a negative regulator of autophagy in skeletal muscle: in response to starvation, enters the nucleus, binds the promoters of autophagy genes and represses their expression, preventing proteolysis of skeletal muscle proteins (By similarity). In addition to the 5'-GTAAACA-3' DNA motif, also binds the 5'-TGANTCA-3' palindromic DNA motif, and co-associates with JUN/AP-1 to activate transcription (PubMed:22083952). Also able to bind to a minimal DNA heteroduplex containing a G/T-mismatch with 5'-TRT[G/T]NB-3' sequence (PubMed:20097901). Binds to NFAT-like motifs (purine-rich) in the IL2 promoter (PubMed:1339390). Positively regulates WNT/beta-catenin signaling by translocating DVL proteins into the nucleus (PubMed:25805136). Also binds to HIV-1 long terminal repeat. May be involved in both positive and negative regulation of important viral and cellular promoter elements (PubMed:1909027). {ECO:0000250|UniProtKB:Q3UCQ1, ECO:0000269|PubMed:1339390, ECO:0000269|PubMed:1909027, ECO:0000269|PubMed:20097901, ECO:0000269|PubMed:22083952, ECO:0000269|PubMed:25451922, ECO:0000269|PubMed:25805136}.</span>
tr_fav_sp[<span class="kw">grepl</span>(<span class="st">&quot;FOX&quot;</span>, tr_fav_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt; [1] ID                   begin                msa_original        </span>
<span class="co">#&gt; [4] repeat_region_length l_type               prot_name           </span>
<span class="co">#&gt; [7] protein_name         gene_names           prot_function       </span>
<span class="co">#&gt; &lt;0 rows&gt; (or 0-length row.names)</span>
tr_unfav_sp[<span class="kw">grepl</span>(<span class="st">&quot;FOX&quot;</span>, tr_unfav_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt;        ID begin        msa_original repeat_region_length l_type</span>
<span class="co">#&gt; 26 Q12948   438         S,S,S,S,S,S                    6   homo</span>
<span class="co">#&gt; 27 Q12948   447 G,G,G,G,G,G,G,G,G,G                   10   homo</span>
<span class="co">#&gt; 28 Q12948   375         G,G,G,G,G,G                    6   homo</span>
<span class="co">#&gt; 29 Q12948   488     A,A,A,A,A,A,A,A                    8   homo</span>
<span class="co">#&gt; 30 Q12948    28         A,A,A,A,A,A                    6   homo</span>
<span class="co">#&gt;      prot_name</span>
<span class="co">#&gt; 26 FOXC1_HUMAN</span>
<span class="co">#&gt; 27 FOXC1_HUMAN</span>
<span class="co">#&gt; 28 FOXC1_HUMAN</span>
<span class="co">#&gt; 29 FOXC1_HUMAN</span>
<span class="co">#&gt; 30 FOXC1_HUMAN</span>
<span class="co">#&gt;                                                                                                    protein_name</span>
<span class="co">#&gt; 26 Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3)</span>
<span class="co">#&gt; 27 Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3)</span>
<span class="co">#&gt; 28 Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3)</span>
<span class="co">#&gt; 29 Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3)</span>
<span class="co">#&gt; 30 Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3)</span>
<span class="co">#&gt;            gene_names</span>
<span class="co">#&gt; 26 FOXC1 FKHL7 FREAC3</span>
<span class="co">#&gt; 27 FOXC1 FKHL7 FREAC3</span>
<span class="co">#&gt; 28 FOXC1 FKHL7 FREAC3</span>
<span class="co">#&gt; 29 FOXC1 FKHL7 FREAC3</span>
<span class="co">#&gt; 30 FOXC1 FKHL7 FREAC3</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     prot_function</span>
<span class="co">#&gt; 26 FUNCTION: DNA-binding transcriptional factor that plays a role in a broad range of cellular and developmental processes such as eye, bones, cardiovascular, kidney and skin development (PubMed:11782474, PubMed:15299087, PubMed:15684392, PubMed:16492674, PubMed:27907090, PubMed:14506133, PubMed:14578375, PubMed:15277473, PubMed:16449236, PubMed:17210863, PubMed:19793056, PubMed:19279310, PubMed:25786029, PubMed:27804176). Acts either as a transcriptional activator or repressor (PubMed:11782474). Binds to the consensus binding site 5'-[G/C][A/T]AAA[T/C]AA[A/C]-3' in promoter of target genes (PubMed:7957066, PubMed:11782474, PubMed:12533514, PubMed:14506133, PubMed:19793056, PubMed:27804176). Upon DNA-binding, promotes DNA bending (PubMed:7957066, PubMed:14506133). Acts as a transcriptional coactivator (PubMed:26565916). Stimulates Indian hedgehog (Ihh)-induced target gene expression mediated by the transcription factor GLI2, and hence regulates endochondral ossification (By similarity). Acts also as a transcriptional coregulator by increasing DNA-binding capacity of GLI2 in breast cancer cells (PubMed:26565916). Regulates FOXO1 through binding to a conserved element, 5'-GTAAACAAA-3' in its promoter region, implicating FOXC1 as an important regulator of cell viability and resistance to oxidative stress in the eye (PubMed:17993506). Cooperates with transcription factor FOXC2 in regulating expression of genes that maintain podocyte integrity (By similarity). Promotes cell growth inhibition by stopping the cell cycle in the G1 phase through TGFB1-mediated signals (PubMed:12408963). Involved in epithelial-mesenchymal transition (EMT) induction by increasing cell proliferation, migration and invasion (PubMed:20406990, PubMed:22991501). Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). Plays a role in the gene regulatory network essential for epidermal keratinocyte terminal differentiation (PubMed:27907090). Essential developmental transcriptional factor required for mesoderm-derived tissues, such as the somites, skin, bone and cartilage. Positively regulates CXCL12 and stem cell factor expression in bone marrow mesenchymal progenitor cells, and hence plays a role in the development and maintenance of mesenchymal niches for haematopoietic stem and progenitor cells (HSPC). Plays a role in corneal transparency by preventing both blood vessel and lymphatic vessel growth during embryonic development in a VEGF-dependent manner. Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). May function as a tumor suppressor (PubMed:12408963). {ECO:0000250|UniProtKB:Q61572, ECO:0000269|PubMed:11782474, ECO:0000269|PubMed:12408963, ECO:0000269|PubMed:12533514, ECO:0000269|PubMed:14506133, ECO:0000269|PubMed:14578375, ECO:0000269|PubMed:15277473, ECO:0000269|PubMed:15299087, ECO:0000269|PubMed:15684392, ECO:0000269|PubMed:16449236, ECO:0000269|PubMed:16492674, ECO:0000269|PubMed:17210863, ECO:0000269|PubMed:17993506, ECO:0000269|PubMed:19279310, ECO:0000269|PubMed:19793056, ECO:0000269|PubMed:20406990, ECO:0000269|PubMed:22991501, ECO:0000269|PubMed:25786029, ECO:0000269|PubMed:26565916, ECO:0000269|PubMed:27804176, ECO:0000269|PubMed:27907090, ECO:0000269|PubMed:7957066}.</span>
<span class="co">#&gt; 27 FUNCTION: DNA-binding transcriptional factor that plays a role in a broad range of cellular and developmental processes such as eye, bones, cardiovascular, kidney and skin development (PubMed:11782474, PubMed:15299087, PubMed:15684392, PubMed:16492674, PubMed:27907090, PubMed:14506133, PubMed:14578375, PubMed:15277473, PubMed:16449236, PubMed:17210863, PubMed:19793056, PubMed:19279310, PubMed:25786029, PubMed:27804176). Acts either as a transcriptional activator or repressor (PubMed:11782474). Binds to the consensus binding site 5'-[G/C][A/T]AAA[T/C]AA[A/C]-3' in promoter of target genes (PubMed:7957066, PubMed:11782474, PubMed:12533514, PubMed:14506133, PubMed:19793056, PubMed:27804176). Upon DNA-binding, promotes DNA bending (PubMed:7957066, PubMed:14506133). Acts as a transcriptional coactivator (PubMed:26565916). Stimulates Indian hedgehog (Ihh)-induced target gene expression mediated by the transcription factor GLI2, and hence regulates endochondral ossification (By similarity). Acts also as a transcriptional coregulator by increasing DNA-binding capacity of GLI2 in breast cancer cells (PubMed:26565916). Regulates FOXO1 through binding to a conserved element, 5'-GTAAACAAA-3' in its promoter region, implicating FOXC1 as an important regulator of cell viability and resistance to oxidative stress in the eye (PubMed:17993506). Cooperates with transcription factor FOXC2 in regulating expression of genes that maintain podocyte integrity (By similarity). Promotes cell growth inhibition by stopping the cell cycle in the G1 phase through TGFB1-mediated signals (PubMed:12408963). Involved in epithelial-mesenchymal transition (EMT) induction by increasing cell proliferation, migration and invasion (PubMed:20406990, PubMed:22991501). Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). Plays a role in the gene regulatory network essential for epidermal keratinocyte terminal differentiation (PubMed:27907090). Essential developmental transcriptional factor required for mesoderm-derived tissues, such as the somites, skin, bone and cartilage. Positively regulates CXCL12 and stem cell factor expression in bone marrow mesenchymal progenitor cells, and hence plays a role in the development and maintenance of mesenchymal niches for haematopoietic stem and progenitor cells (HSPC). Plays a role in corneal transparency by preventing both blood vessel and lymphatic vessel growth during embryonic development in a VEGF-dependent manner. Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). May function as a tumor suppressor (PubMed:12408963). {ECO:0000250|UniProtKB:Q61572, ECO:0000269|PubMed:11782474, ECO:0000269|PubMed:12408963, ECO:0000269|PubMed:12533514, ECO:0000269|PubMed:14506133, ECO:0000269|PubMed:14578375, ECO:0000269|PubMed:15277473, ECO:0000269|PubMed:15299087, ECO:0000269|PubMed:15684392, ECO:0000269|PubMed:16449236, ECO:0000269|PubMed:16492674, ECO:0000269|PubMed:17210863, ECO:0000269|PubMed:17993506, ECO:0000269|PubMed:19279310, ECO:0000269|PubMed:19793056, ECO:0000269|PubMed:20406990, ECO:0000269|PubMed:22991501, ECO:0000269|PubMed:25786029, ECO:0000269|PubMed:26565916, ECO:0000269|PubMed:27804176, ECO:0000269|PubMed:27907090, ECO:0000269|PubMed:7957066}.</span>
<span class="co">#&gt; 28 FUNCTION: DNA-binding transcriptional factor that plays a role in a broad range of cellular and developmental processes such as eye, bones, cardiovascular, kidney and skin development (PubMed:11782474, PubMed:15299087, PubMed:15684392, PubMed:16492674, PubMed:27907090, PubMed:14506133, PubMed:14578375, PubMed:15277473, PubMed:16449236, PubMed:17210863, PubMed:19793056, PubMed:19279310, PubMed:25786029, PubMed:27804176). Acts either as a transcriptional activator or repressor (PubMed:11782474). Binds to the consensus binding site 5'-[G/C][A/T]AAA[T/C]AA[A/C]-3' in promoter of target genes (PubMed:7957066, PubMed:11782474, PubMed:12533514, PubMed:14506133, PubMed:19793056, PubMed:27804176). Upon DNA-binding, promotes DNA bending (PubMed:7957066, PubMed:14506133). Acts as a transcriptional coactivator (PubMed:26565916). Stimulates Indian hedgehog (Ihh)-induced target gene expression mediated by the transcription factor GLI2, and hence regulates endochondral ossification (By similarity). Acts also as a transcriptional coregulator by increasing DNA-binding capacity of GLI2 in breast cancer cells (PubMed:26565916). Regulates FOXO1 through binding to a conserved element, 5'-GTAAACAAA-3' in its promoter region, implicating FOXC1 as an important regulator of cell viability and resistance to oxidative stress in the eye (PubMed:17993506). Cooperates with transcription factor FOXC2 in regulating expression of genes that maintain podocyte integrity (By similarity). Promotes cell growth inhibition by stopping the cell cycle in the G1 phase through TGFB1-mediated signals (PubMed:12408963). Involved in epithelial-mesenchymal transition (EMT) induction by increasing cell proliferation, migration and invasion (PubMed:20406990, PubMed:22991501). Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). Plays a role in the gene regulatory network essential for epidermal keratinocyte terminal differentiation (PubMed:27907090). Essential developmental transcriptional factor required for mesoderm-derived tissues, such as the somites, skin, bone and cartilage. Positively regulates CXCL12 and stem cell factor expression in bone marrow mesenchymal progenitor cells, and hence plays a role in the development and maintenance of mesenchymal niches for haematopoietic stem and progenitor cells (HSPC). Plays a role in corneal transparency by preventing both blood vessel and lymphatic vessel growth during embryonic development in a VEGF-dependent manner. Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). May function as a tumor suppressor (PubMed:12408963). {ECO:0000250|UniProtKB:Q61572, ECO:0000269|PubMed:11782474, ECO:0000269|PubMed:12408963, ECO:0000269|PubMed:12533514, ECO:0000269|PubMed:14506133, ECO:0000269|PubMed:14578375, ECO:0000269|PubMed:15277473, ECO:0000269|PubMed:15299087, ECO:0000269|PubMed:15684392, ECO:0000269|PubMed:16449236, ECO:0000269|PubMed:16492674, ECO:0000269|PubMed:17210863, ECO:0000269|PubMed:17993506, ECO:0000269|PubMed:19279310, ECO:0000269|PubMed:19793056, ECO:0000269|PubMed:20406990, ECO:0000269|PubMed:22991501, ECO:0000269|PubMed:25786029, ECO:0000269|PubMed:26565916, ECO:0000269|PubMed:27804176, ECO:0000269|PubMed:27907090, ECO:0000269|PubMed:7957066}.</span>
<span class="co">#&gt; 29 FUNCTION: DNA-binding transcriptional factor that plays a role in a broad range of cellular and developmental processes such as eye, bones, cardiovascular, kidney and skin development (PubMed:11782474, PubMed:15299087, PubMed:15684392, PubMed:16492674, PubMed:27907090, PubMed:14506133, PubMed:14578375, PubMed:15277473, PubMed:16449236, PubMed:17210863, PubMed:19793056, PubMed:19279310, PubMed:25786029, PubMed:27804176). Acts either as a transcriptional activator or repressor (PubMed:11782474). Binds to the consensus binding site 5'-[G/C][A/T]AAA[T/C]AA[A/C]-3' in promoter of target genes (PubMed:7957066, PubMed:11782474, PubMed:12533514, PubMed:14506133, PubMed:19793056, PubMed:27804176). Upon DNA-binding, promotes DNA bending (PubMed:7957066, PubMed:14506133). Acts as a transcriptional coactivator (PubMed:26565916). Stimulates Indian hedgehog (Ihh)-induced target gene expression mediated by the transcription factor GLI2, and hence regulates endochondral ossification (By similarity). Acts also as a transcriptional coregulator by increasing DNA-binding capacity of GLI2 in breast cancer cells (PubMed:26565916). Regulates FOXO1 through binding to a conserved element, 5'-GTAAACAAA-3' in its promoter region, implicating FOXC1 as an important regulator of cell viability and resistance to oxidative stress in the eye (PubMed:17993506). Cooperates with transcription factor FOXC2 in regulating expression of genes that maintain podocyte integrity (By similarity). Promotes cell growth inhibition by stopping the cell cycle in the G1 phase through TGFB1-mediated signals (PubMed:12408963). Involved in epithelial-mesenchymal transition (EMT) induction by increasing cell proliferation, migration and invasion (PubMed:20406990, PubMed:22991501). Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). Plays a role in the gene regulatory network essential for epidermal keratinocyte terminal differentiation (PubMed:27907090). Essential developmental transcriptional factor required for mesoderm-derived tissues, such as the somites, skin, bone and cartilage. Positively regulates CXCL12 and stem cell factor expression in bone marrow mesenchymal progenitor cells, and hence plays a role in the development and maintenance of mesenchymal niches for haematopoietic stem and progenitor cells (HSPC). Plays a role in corneal transparency by preventing both blood vessel and lymphatic vessel growth during embryonic development in a VEGF-dependent manner. Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). May function as a tumor suppressor (PubMed:12408963). {ECO:0000250|UniProtKB:Q61572, ECO:0000269|PubMed:11782474, ECO:0000269|PubMed:12408963, ECO:0000269|PubMed:12533514, ECO:0000269|PubMed:14506133, ECO:0000269|PubMed:14578375, ECO:0000269|PubMed:15277473, ECO:0000269|PubMed:15299087, ECO:0000269|PubMed:15684392, ECO:0000269|PubMed:16449236, ECO:0000269|PubMed:16492674, ECO:0000269|PubMed:17210863, ECO:0000269|PubMed:17993506, ECO:0000269|PubMed:19279310, ECO:0000269|PubMed:19793056, ECO:0000269|PubMed:20406990, ECO:0000269|PubMed:22991501, ECO:0000269|PubMed:25786029, ECO:0000269|PubMed:26565916, ECO:0000269|PubMed:27804176, ECO:0000269|PubMed:27907090, ECO:0000269|PubMed:7957066}.</span>
<span class="co">#&gt; 30 FUNCTION: DNA-binding transcriptional factor that plays a role in a broad range of cellular and developmental processes such as eye, bones, cardiovascular, kidney and skin development (PubMed:11782474, PubMed:15299087, PubMed:15684392, PubMed:16492674, PubMed:27907090, PubMed:14506133, PubMed:14578375, PubMed:15277473, PubMed:16449236, PubMed:17210863, PubMed:19793056, PubMed:19279310, PubMed:25786029, PubMed:27804176). Acts either as a transcriptional activator or repressor (PubMed:11782474). Binds to the consensus binding site 5'-[G/C][A/T]AAA[T/C]AA[A/C]-3' in promoter of target genes (PubMed:7957066, PubMed:11782474, PubMed:12533514, PubMed:14506133, PubMed:19793056, PubMed:27804176). Upon DNA-binding, promotes DNA bending (PubMed:7957066, PubMed:14506133). Acts as a transcriptional coactivator (PubMed:26565916). Stimulates Indian hedgehog (Ihh)-induced target gene expression mediated by the transcription factor GLI2, and hence regulates endochondral ossification (By similarity). Acts also as a transcriptional coregulator by increasing DNA-binding capacity of GLI2 in breast cancer cells (PubMed:26565916). Regulates FOXO1 through binding to a conserved element, 5'-GTAAACAAA-3' in its promoter region, implicating FOXC1 as an important regulator of cell viability and resistance to oxidative stress in the eye (PubMed:17993506). Cooperates with transcription factor FOXC2 in regulating expression of genes that maintain podocyte integrity (By similarity). Promotes cell growth inhibition by stopping the cell cycle in the G1 phase through TGFB1-mediated signals (PubMed:12408963). Involved in epithelial-mesenchymal transition (EMT) induction by increasing cell proliferation, migration and invasion (PubMed:20406990, PubMed:22991501). Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). Plays a role in the gene regulatory network essential for epidermal keratinocyte terminal differentiation (PubMed:27907090). Essential developmental transcriptional factor required for mesoderm-derived tissues, such as the somites, skin, bone and cartilage. Positively regulates CXCL12 and stem cell factor expression in bone marrow mesenchymal progenitor cells, and hence plays a role in the development and maintenance of mesenchymal niches for haematopoietic stem and progenitor cells (HSPC). Plays a role in corneal transparency by preventing both blood vessel and lymphatic vessel growth during embryonic development in a VEGF-dependent manner. Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression (By similarity). May function as a tumor suppressor (PubMed:12408963). {ECO:0000250|UniProtKB:Q61572, ECO:0000269|PubMed:11782474, ECO:0000269|PubMed:12408963, ECO:0000269|PubMed:12533514, ECO:0000269|PubMed:14506133, ECO:0000269|PubMed:14578375, ECO:0000269|PubMed:15277473, ECO:0000269|PubMed:15299087, ECO:0000269|PubMed:15684392, ECO:0000269|PubMed:16449236, ECO:0000269|PubMed:16492674, ECO:0000269|PubMed:17210863, ECO:0000269|PubMed:17993506, ECO:0000269|PubMed:19279310, ECO:0000269|PubMed:19793056, ECO:0000269|PubMed:20406990, ECO:0000269|PubMed:22991501, ECO:0000269|PubMed:25786029, ECO:0000269|PubMed:26565916, ECO:0000269|PubMed:27804176, ECO:0000269|PubMed:27907090, ECO:0000269|PubMed:7957066}.</span></code></pre></div>
<p>In each protein FOXK1 and FOXK2 we could detect two TR-regions: A polyA homo-TR near the N-terminus and a micro-TR near the C-terminus. In FOXK1 the polyA homo-TR falls in the interaction domain with SIN3A. FOXK1 toghether with SIN3A cooperatively regulate cell cycle progression <a href="http://dx.doi.org/10.1016/S0092-8674(02)00810-3">TODO</a>.</p>
<p>Forkhead box protein C1 (FOXC1) in contrast is part of the CRC unfavorable associated proteins. FOXC1 acts as a transcriptional activator where the crucial domains are located at the C- and N-termini. Most of the detected TRs fall exactely in these regions responsible for transcriptional activation <a href="https://doi.org/10.1074/jbc.M110266200">TODO</a>. The C-terminal end 366-553 is the proposed binding region of a degradation factor <a href="https://doi.org/10.1074/jbc.M513629200">TODO</a> and the region 47-553 could be shown to bind to PITX2 <a href="https://doi.org/10.1093/hmg/ddl008">TODO</a> supporting the idea of TRs acting as keyplayers in protein-protein interactions. To our knowledge, no structural interaction data is available to further prove this hypothesis.</p>
<p>Interestingly, in both FOXK and FOXC proteins the forkhead box didn’t show any TRs - they are rather clustered around the forkhead box.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">which</span>(tr_wnt_sp<span class="op">$</span>ID <span class="op">==</span><span class="st"> &quot;O00358&quot;</span>),sel_var]
<span class="co">#&gt;       ID begin                    msa_original repeat_region_length l_type</span>
<span class="co">#&gt; 2 O00358   164 A,A,A,A,A,A,A,A,A,A,A,A,A,A,A,A                   16   homo</span>
<span class="co">#&gt;     prot_name</span>
<span class="co">#&gt; 2 FOXE1_HUMAN</span>
<span class="co">#&gt;                                                                                                                                                                    protein_name</span>
<span class="co">#&gt; 2 Forkhead box protein E1 (Forkhead box protein E2) (Forkhead-related protein FKHL15) (HFKH4) (HNF-3/fork head-like protein 5) (HFKL5) (Thyroid transcription factor 2) (TTF-2)</span>
<span class="co">#&gt;                      gene_names</span>
<span class="co">#&gt; 2 FOXE1 FKHL15 FOXE2 TITF2 TTF2</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      prot_function</span>
<span class="co">#&gt; 2 FUNCTION: Transcription factor that binds consensus sites on a variety of gene promoters and activate their transcription. Involved in proper palate formation, most probably through the expression of MSX1 and TGFB3 genes which are direct targets of this transcription factor. Also implicated in thyroid gland morphogenesis. May indirectly play a role in cell growth and migration through the regulation of WNT5A expression. {ECO:0000269|PubMed:12165566, ECO:0000269|PubMed:16882747, ECO:0000269|PubMed:20094846, ECO:0000269|PubMed:20484477, ECO:0000269|PubMed:21177256, ECO:0000269|PubMed:24219130, ECO:0000269|PubMed:25381600, ECO:0000269|PubMed:9697705}.</span>
tr_unfav_sp[<span class="kw">which</span>(tr_unfav_sp<span class="op">$</span>ID <span class="op">==</span><span class="st"> &quot;P10070&quot;</span>),sel_var]
<span class="co">#&gt; [1] ID                   begin                msa_original        </span>
<span class="co">#&gt; [4] repeat_region_length l_type               prot_name           </span>
<span class="co">#&gt; [7] protein_name         gene_names           prot_function       </span>
<span class="co">#&gt; &lt;0 rows&gt; (or 0-length row.names)</span></code></pre></div>
<p><em>FOXE1</em> is one of the prognostic colorectal cancer genes and can indirectly activate the Wnt/<span class="math inline">\(\beta\)</span>-catenin pathway <a href="https://doi.org/10.1002/jcp.28399">TODO</a> and shows a central poly-A TR-region.</p>
</div>
<div id="wnt-receptor-complex" class="section level2">
<h2>Wnt Receptor Complex</h2>
<p>The Wnt Receptor Complex is made up of Wnt, Frizzled (Fz), G-protein coupled receptors (GPCRs), lipoprotein receptor-related protein (LRP), receptor tyrosine kinase (RTK) and ROR.</p>
<div id="frizzled" class="section level3">
<h3>Frizzled</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">grepl</span>(<span class="st">&quot;FZ&quot;</span>, tr_wnt_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt;         ID begin msa_original repeat_region_length l_type  prot_name</span>
<span class="co">#&gt; 74  Q13467    12  L,L,L,L,L,L                    6   homo FZD5_HUMAN</span>
<span class="co">#&gt; 149 Q9H461   211  G,G,G,G,G,G                    6   homo FZD8_HUMAN</span>
<span class="co">#&gt;                        protein_name   gene_names</span>
<span class="co">#&gt; 74  Frizzled-5 (Fz-5) (hFz5) (FzE5) FZD5 C2orf31</span>
<span class="co">#&gt; 149        Frizzled-8 (Fz-8) (hFz8)         FZD8</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           prot_function</span>
<span class="co">#&gt; 74  FUNCTION: Receptor for Wnt proteins (PubMed:9054360, PubMed:10097073, PubMed:20530549). Can activate WNT2, WNT10B, WNT5A, but not WNT2B or WNT4 (in vitro); the in vivo situation may be different since not all of these are known to be coexpressed (By similarity). In neurons, activation of WNT7A promotes formation of synapses (PubMed:20530549). Functions in the canonical Wnt/beta-catenin signaling pathway. The canonical Wnt/beta-catenin signaling pathway leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes (By similarity). A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues (Probable). Plays a role in yolk sac angiogenesis and in placental vascularization (By similarity). {ECO:0000250|UniProtKB:Q9EQD0, ECO:0000269|PubMed:10097073, ECO:0000269|PubMed:20530549, ECO:0000269|PubMed:9054360, ECO:0000305}.</span>
<span class="co">#&gt; 149                                                                                                                                                                                                                                                                                                                                                                          FUNCTION: Receptor for Wnt proteins. Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalosomes. The beta-catenin canonical signaling pathway leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. Coreceptor along with RYK of Wnt proteins, such as WNT1. {ECO:0000269|PubMed:11448771}.</span></code></pre></div>
<p>Frizzled membran proteins are receptors of Wnt activating Dishevelled proteins. In FZD5 and FZD8 we could detect polyL and polyG homo-TR near the C- and N-terminus respectively. The polyL TR in FZD5 is near but not within the Frizzled domain and on the opposite terminus from the DVL binding site. In FZD8, the polyG TR-region is extracellular forming a helical structure which is in topological proximity to the Wnt binding site.</p>
</div>
<div id="wnt" class="section level3">
<h3>WNT</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">grepl</span>(<span class="st">&quot;WNT&quot;</span>, tr_wnt_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt;         ID begin  msa_original repeat_region_length l_type   prot_name</span>
<span class="co">#&gt; 124 Q93097    44 L,L,L,L,L,L,L                    7   homo WNT2B_HUMAN</span>
<span class="co">#&gt; 192 Q9Y6F9    11 L,L,L,L,L,L,L                    7   homo  WNT6_HUMAN</span>
<span class="co">#&gt;                        protein_name  gene_names</span>
<span class="co">#&gt; 124 Protein Wnt-2b (Protein Wnt-13) WNT2B WNT13</span>
<span class="co">#&gt; 192                   Protein Wnt-6        WNT6</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                                                                           prot_function</span>
<span class="co">#&gt; 124                                                                                                                                                                                                                                          FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. Functions in the canonical Wnt/beta-catenin signaling pathway. Plays a redundant role in embryonic lung development. {ECO:0000250|UniProtKB:O70283}.</span>
<span class="co">#&gt; 192 FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. Probable developmental protein. May be a signaling molecule which affects the development of discrete regions of tissues. Is likely to signal over only few cell diameters. Together with CAV1 may promote chemoresistance of gastric cancer cells to DNA-damaging anthracycline drugs through the activation of the canonical Wnt receptor signaling pathway. {ECO:0000269|PubMed:22370641}.</span></code></pre></div>
<p>In WNT2B and WNT6 polyL homo-TRs are located near the N-terminus in a signal peptide domain which is the important part of interaction with signal recognition particles in the process of nuclear translocation.</p>
</div>
<div id="lrp" class="section level3">
<h3>LRP</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">grepl</span>(<span class="st">&quot;LRP&quot;</span>, tr_wnt_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt;        ID begin      msa_original repeat_region_length l_type  prot_name</span>
<span class="co">#&gt; 17 O75197  1482     S,S,S,S,S,S,S                    7   homo LRP5_HUMAN</span>
<span class="co">#&gt; 18 O75197    12 L,L,L,L,L,L,L,L,L                    9   homo LRP5_HUMAN</span>
<span class="co">#&gt; 19 O75581  1469     S,S,S,S,S,S,S                    7   homo LRP6_HUMAN</span>
<span class="co">#&gt; 71 Q07954  4428     L,L,L,L,L,L,L                    7   homo LRP1_HUMAN</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                              protein_name</span>
<span class="co">#&gt; 17                                                                                                                                                                                                                                                                                                Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)</span>
<span class="co">#&gt; 18                                                                                                                                                                                                                                                                                                Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)</span>
<span class="co">#&gt; 19                                                                                                                                                                                                                                                                                                                                                             Low-density lipoprotein receptor-related protein 6 (LRP-6)</span>
<span class="co">#&gt; 71 Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]</span>
<span class="co">#&gt;       gene_names</span>
<span class="co">#&gt; 17 LRP5 LR3 LRP7</span>
<span class="co">#&gt; 18 LRP5 LR3 LRP7</span>
<span class="co">#&gt; 19          LRP6</span>
<span class="co">#&gt; 71 LRP1 A2MR APR</span>
<span class="co">#&gt;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             prot_function</span>
<span class="co">#&gt; 17 FUNCTION: Acts as a coreceptor with members of the frizzled family of seven-transmembrane spanning receptors to transduce signal by Wnt proteins (PubMed:11336703, PubMed:11448771, PubMed:15778503, PubMed:11719191, PubMed:15908424, PubMed:16252235). Activates the canonical Wnt signaling pathway that controls cell fate determination and self-renewal during embryonic development and adult tissue regeneration (PubMed:11336703, PubMed:11719191). In particular, may play an important role in the development of the posterior patterning of the epiblast during gastrulation (By similarity). During bone development, regulates osteoblast proliferation and differentiation thus determining bone mass (PubMed:11719191). Mechanistically, the formation of the signaling complex between Wnt ligand, frizzled receptor and LRP5 coreceptor promotes the recruitment of AXIN1 to LRP5, stabilizing beta-catenin/CTNNB1 and activating TCF/LEF-mediated transcriptional programs (PubMed:11336703, PubMed:25920554, PubMed:24706814, PubMed:14731402). Acts as a coreceptor for non-Wnt proteins, such as norrin/NDP. Binding of norrin/NDP to frizzled 4/FZD4-LRP5 receptor complex triggers beta-catenin/CTNNB1-dependent signaling known to be required for retinal vascular development (PubMed:27228167, PubMed:16252235). Plays a role in controlling postnatal vascular regression in retina via macrophage-induced endothelial cell apoptosis (By similarity). {ECO:0000250|UniProtKB:Q91VN0, ECO:0000269|PubMed:11336703, ECO:0000269|PubMed:11448771, ECO:0000269|PubMed:11719191, ECO:0000269|PubMed:14731402, ECO:0000269|PubMed:15778503, ECO:0000269|PubMed:15908424, ECO:0000269|PubMed:16252235, ECO:0000269|PubMed:24706814, ECO:0000269|PubMed:25920554, ECO:0000269|PubMed:27228167}.</span>
<span class="co">#&gt; 18 FUNCTION: Acts as a coreceptor with members of the frizzled family of seven-transmembrane spanning receptors to transduce signal by Wnt proteins (PubMed:11336703, PubMed:11448771, PubMed:15778503, PubMed:11719191, PubMed:15908424, PubMed:16252235). Activates the canonical Wnt signaling pathway that controls cell fate determination and self-renewal during embryonic development and adult tissue regeneration (PubMed:11336703, PubMed:11719191). In particular, may play an important role in the development of the posterior patterning of the epiblast during gastrulation (By similarity). During bone development, regulates osteoblast proliferation and differentiation thus determining bone mass (PubMed:11719191). Mechanistically, the formation of the signaling complex between Wnt ligand, frizzled receptor and LRP5 coreceptor promotes the recruitment of AXIN1 to LRP5, stabilizing beta-catenin/CTNNB1 and activating TCF/LEF-mediated transcriptional programs (PubMed:11336703, PubMed:25920554, PubMed:24706814, PubMed:14731402). Acts as a coreceptor for non-Wnt proteins, such as norrin/NDP. Binding of norrin/NDP to frizzled 4/FZD4-LRP5 receptor complex triggers beta-catenin/CTNNB1-dependent signaling known to be required for retinal vascular development (PubMed:27228167, PubMed:16252235). Plays a role in controlling postnatal vascular regression in retina via macrophage-induced endothelial cell apoptosis (By similarity). {ECO:0000250|UniProtKB:Q91VN0, ECO:0000269|PubMed:11336703, ECO:0000269|PubMed:11448771, ECO:0000269|PubMed:11719191, ECO:0000269|PubMed:14731402, ECO:0000269|PubMed:15778503, ECO:0000269|PubMed:15908424, ECO:0000269|PubMed:16252235, ECO:0000269|PubMed:24706814, ECO:0000269|PubMed:25920554, ECO:0000269|PubMed:27228167}.</span>
<span class="co">#&gt; 19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            FUNCTION: Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalsomes. Cell-surface coreceptor of Wnt/beta-catenin signaling, which plays a pivotal role in bone formation. The Wnt-induced Fzd/LRP6 coreceptor complex recruits DVL1 polymers to the plasma membrane which, in turn, recruits the AXIN1/GSK3B-complex to the cell surface promoting the formation of signalsomes and inhibiting AXIN1/GSK3-mediated phosphorylation and destruction of beta-catenin. Required for posterior patterning of the epiblast during gastrulation (By similarity). {ECO:0000250, ECO:0000269|PubMed:11357136, ECO:0000269|PubMed:11448771, ECO:0000269|PubMed:15778503, ECO:0000269|PubMed:16341017, ECO:0000269|PubMed:16513652, ECO:0000269|PubMed:17326769, ECO:0000269|PubMed:17400545, ECO:0000269|PubMed:19107203, ECO:0000269|PubMed:19293931, ECO:0000269|PubMed:19801552}.</span>
<span class="co">#&gt; 71                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       FUNCTION: Endocytic receptor involved in endocytosis and in phagocytosis of apoptotic cells. Required for early embryonic development. Involved in cellular lipid homeostasis. Involved in the plasma clearance of chylomicron remnants and activated LRPAP1 (alpha 2-macroglobulin), as well as the local metabolism of complexes between plasminogen activators and their endogenous inhibitors. May modulate cellular events, such as APP metabolism, kinase-dependent intracellular signaling, neuronal calcium signaling as well as neurotransmission (PubMed:11907044, PubMed:12888553, PubMed:12713657). Acts as an alpha-2-macroglobulin receptor (PubMed:26142438). {ECO:0000269|PubMed:11907044, ECO:0000269|PubMed:12713657, ECO:0000269|PubMed:12888553, ECO:0000269|PubMed:26142438}.; FUNCTION: (Microbial infection) Functions as a receptor for Pseudomonas aeruginosa exotoxin A. {ECO:0000269|PubMed:1618748}.</span></code></pre></div>
<p>LRP5 has a polyL homo-TR in its signal peptide at the N-terminus and a polyS homo-TR near the C-terminus. The later is also found at a similar location in LRP6. To our knowledge there is not much known today about those regions at the C-terminus. In LRP1 the N-terminal polyL homo-TR is located in a helical transmembran peptide in a possible Low-density lipoprotein receptor region. In the canonical Wnt-pathway only LRP5 and LRP6 are reported to be involved.</p>
</div>
<div id="receptor-tyrosine-kinase-tyrosine-protein-kinase-transmembrane-receptor" class="section level3">
<h3>Receptor Tyrosine Kinase &amp; Tyrosine-protein kinase transmembrane receptor</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">tr_wnt_sp[<span class="kw">grepl</span>(<span class="st">&quot;PTK&quot;</span>, tr_wnt_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt; [1] ID                   begin                msa_original        </span>
<span class="co">#&gt; [4] repeat_region_length l_type               prot_name           </span>
<span class="co">#&gt; [7] protein_name         gene_names           prot_function       </span>
<span class="co">#&gt; &lt;0 rows&gt; (or 0-length row.names)</span>
tr_wnt_sp[<span class="kw">grepl</span>(<span class="st">&quot;ROR&quot;</span>, tr_wnt_sp<span class="op">$</span>prot_name),sel_var]
<span class="co">#&gt; [1] ID                   begin                msa_original        </span>
<span class="co">#&gt; [4] repeat_region_length l_type               prot_name           </span>
<span class="co">#&gt; [7] protein_name         gene_names           prot_function       </span>
<span class="co">#&gt; &lt;0 rows&gt; (or 0-length row.names)</span></code></pre></div>
<p>The inactive tyrosine-protein kinase 7 (PTK7) and Tyrosine-protein kinase transmembrane receptor (ROR2) are mainly involved in the <span class="math inline">\(\beta\)</span>-catenin independent planar cell polarity Wnt-pathway. PTK7 plays an important role in cancer cell invasion <a href="http://dx.doi.org/10.1074/jbc.M110.165159">TODO</a>. ROR2 is shown to suppress the Wnt/<span class="math inline">\(\beta\)</span>-catenin signal and is therefore also an interesting player in the fight against cancer <a href="https://dx.doi.org/10.1371/journal.pone.0102695">TODO</a>. We couldn’t detect in both of those Kinase any TRs as we couldn’t in CKI and GSK3 neither. It is thus possible to hypothesise that protein kinases tend to have few TR in general.</p>
</div>
</div>
<div id="kinases-show-no-tandem-repeat-depletion" class="section level2">
<h2>Kinases Show No Tandem Repeat Depletion</h2>
<p>As we couldn’t detect any TRs in certain protein kinases of the Wnt/<span class="math inline">\(\beta\)</span>-catenin pathway, we’re interested if protein kinases generally lack TRs. We therefore filter the Human Proteome for protein kinases (enzyme commission numbers 2.7.10, 2.7.11, 2.7.12, 2.7.13, 2.7.14, 2.7.99).</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># url to UniProt/Swiss-Prot querying enzyme commissions for protein kinases</span>
url_kin &lt;-<span class="st"> &quot;https://www.uniprot.org/uniprot/?query=ec:2.7.10.-%20OR%20ec:2.7.11.-%20OR%20ec:2.7.12.-%20OR%20ec:2.7.13.-%20OR%20ec:2.7.14.-%20OR%20ec:2.7.99.-&amp;format=fasta&amp;sort=score&amp;fil=proteome:UP000005640%20AND%20reviewed:yes%20AND%20organism:%22Homo%20sapiens%20(Human)%20[9606]%22&quot;</span>
sp_kinIDs &lt;-<span class="st"> </span><span class="kw">load_kinome</span>(<span class="dt">url =</span> url_kin, <span class="dt">path =</span> dest_file_kin, <span class="dt">OnlyIDs =</span> <span class="ot">TRUE</span>)

<span class="co"># No. of protein kinases in Human Proteome</span>
<span class="kw">length</span>(sp_kinIDs)
<span class="co">#&gt; [1] 483</span>
<span class="kw">length</span>(sp_kinIDs) <span class="op">/</span><span class="st"> </span><span class="kw">nrow</span>(sp_all_fav)
<span class="co">#&gt; [1] 0.02365212</span>
<span class="co"># No. protein kinases in Wnt-Pathway</span>
<span class="kw">sum</span>(sp_kinIDs <span class="op">%in%</span><span class="st"> </span>tr_wnt<span class="op">$</span>ID)
<span class="co">#&gt; [1] 11</span>
<span class="kw">sum</span>(sp_kinIDs <span class="op">%in%</span><span class="st"> </span>tr_wnt<span class="op">$</span>ID) <span class="op">/</span><span class="st"> </span><span class="kw">nrow</span>(tr_wnt)
<span class="co">#&gt; [1] 0.05729167</span>
<span class="co"># No. protein kinases in CRC favorable proteins</span>
<span class="kw">sum</span>(sp_kinIDs <span class="op">%in%</span><span class="st"> </span>tr_fav<span class="op">$</span>ID)
<span class="co">#&gt; [1] 2</span>
<span class="co"># No. protein kinases in CRC unfavorable proteins</span>
<span class="kw">sum</span>(sp_kinIDs <span class="op">%in%</span><span class="st"> </span>tr_unfav<span class="op">$</span>ID)
<span class="co">#&gt; [1] 5</span>

(<span class="kw">sum</span>(sp_kinIDs <span class="op">%in%</span><span class="st"> </span>tr_fav<span class="op">$</span>ID) <span class="op">+</span><span class="st"> </span><span class="kw">sum</span>(sp_kinIDs <span class="op">%in%</span><span class="st"> </span>tr_unfav<span class="op">$</span>ID))<span class="op">/</span>(<span class="kw">nrow</span>(tr_fav)<span class="op">+</span><span class="kw">nrow</span>(tr_unfav))
<span class="co">#&gt; [1] 0.0472973</span></code></pre></div>
<p>Of the 483 protein kinases from the Human proteome 11 have TRs and are associated with the Wnt-pathway and 7 have TRs and are CRC related proteins. To put this in relations, of the whole human proteome 2.4% are protein kinases. From proteins with TRs, 4.7% belong to the enzyme class of protein kinases in CRC associated proteins and 5.7% in Wnt-pathway proteins.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">dest_file_kinext &lt;-<span class="st"> &quot;/home/matteo/polybox/MSc_ACLS/master_thesis/TRALResultAnalysis/data/swissprot_human_extkinome.tsv&quot;</span>
url_extkin &lt;-<span class="st"> &quot;https://www.uniprot.org/uniprot/?query=ec:2.7.-.-%20AND%20reviewed:yes%20AND%20organism:%22Homo%20sapiens%20(Human)%20[9606]%22%20AND%20proteome:up000005640&amp;format=fasta&amp;sort=score&quot;</span>
sp_extkinIDS &lt;-<span class="st"> </span><span class="kw">load_kinome</span>(<span class="dt">url =</span> url_extkin, <span class="dt">path =</span> dest_file_kinext, <span class="dt">OnlyIDs =</span> <span class="ot">TRUE</span>)
<span class="co"># No. of protein kinases in Human Proteome</span>
<span class="kw">length</span>(sp_extkinIDS)
<span class="co">#&gt; [1] 737</span>
<span class="kw">length</span>(sp_extkinIDS) <span class="op">/</span><span class="st"> </span><span class="kw">nrow</span>(sp_all_fav)
<span class="co">#&gt; [1] 0.0360903</span>
<span class="co"># No. protein kinases in Wnt-Pathway</span>
<span class="kw">sum</span>(sp_extkinIDS <span class="op">%in%</span><span class="st"> </span>tr_wnt<span class="op">$</span>ID)
<span class="co">#&gt; [1] 11</span>
<span class="kw">sum</span>(sp_extkinIDS <span class="op">%in%</span><span class="st"> </span>tr_wnt<span class="op">$</span>ID) <span class="op">/</span><span class="st"> </span><span class="kw">nrow</span>(tr_wnt)
<span class="co">#&gt; [1] 0.05729167</span>
<span class="co"># No. protein kinases in CRC favorable proteins</span>
<span class="kw">sum</span>(sp_extkinIDS <span class="op">%in%</span><span class="st"> </span>tr_fav<span class="op">$</span>ID)
<span class="co">#&gt; [1] 2</span>
<span class="co"># No. protein kinases in CRC unfavorable proteins</span>
<span class="kw">sum</span>(sp_extkinIDS <span class="op">%in%</span><span class="st"> </span>tr_unfav<span class="op">$</span>ID)
<span class="co">#&gt; [1] 5</span>

(<span class="kw">sum</span>(sp_extkinIDS <span class="op">%in%</span><span class="st"> </span>tr_fav<span class="op">$</span>ID) <span class="op">+</span><span class="st"> </span><span class="kw">sum</span>(sp_extkinIDS <span class="op">%in%</span><span class="st"> </span>tr_unfav<span class="op">$</span>ID))<span class="op">/</span>(<span class="kw">nrow</span>(tr_fav)<span class="op">+</span><span class="kw">nrow</span>(tr_unfav))
<span class="co">#&gt; [1] 0.0472973</span></code></pre></div>
<p>These findings don’t support our hypothesis and even considering all phosphorous transfering enzymes (EC 2.7.-.-) doesn’t show a depletion of TRs.</p>
</div>
</div>
<div id="conclusion" class="section level1">
<h1>Conclusion</h1>
<ul>
<li><p>Often TR-region in lox complexity regions / yet not characterized regions of the protein (see Forkhead. Where the TR-regions encompass the main functional region; OR Kinase. Do they never have TRs?)</p></li>
<li><p>Extracellular or membranlocated proteins show a tendency for homo-TRs in their signal peptide sequence (see Wnt and LRP).</p></li>
<li><p>critically reflect the results, as the sequences are often processed such that different forms of the proteins are available.</p></li>
</ul>
</div>
<div id="notes-thoughts" class="section level1">
<h1>NOTES &amp; THOUGHTS</h1>
<div id="filter-the-top-20-crc-genes" class="section level2">
<h2>Filter the top 20 CRC genes:</h2>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">top20_unfav_genes &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="st">&quot;LRCH4&quot;</span>, <span class="st">&quot;POFUT2&quot;</span>, <span class="st">&quot;CLK3&quot;</span>, <span class="st">&quot;EGFL7&quot;</span>, <span class="st">&quot;DPP7&quot;</span>, <span class="st">&quot;HSH2D&quot;</span>, <span class="st">&quot;ASB6&quot;</span>, <span class="st">&quot;SPAG4&quot;</span>, <span class="st">&quot;EXOC3L4&quot;</span>, <span class="st">&quot;HSPA1A&quot;</span>, <span class="st">&quot;PAQR6&quot;</span>, <span class="st">&quot;FAM69B&quot;</span>, <span class="st">&quot;CRACR2B&quot;</span>, <span class="st">&quot;ARHGAP4&quot;</span>, <span class="st">&quot;NPDC1&quot;</span>, <span class="st">&quot;DAPK1&quot;</span>, <span class="st">&quot;CNPY3&quot;</span>, <span class="st">&quot;ARL8A&quot;</span>, <span class="st">&quot;INAFM1&quot;</span>, <span class="st">&quot;RHBDD2&quot;</span>)
(<span class="kw">getTRbyGene</span>(<span class="dt">tr_sp =</span> tr_unfav_sp, <span class="dt">genes =</span> top20_unfav_genes))
<span class="co">#&gt; [1] &quot;No protein with TRs found in this gene(s).&quot;</span>
<span class="co">#&gt; [1] &quot;No protein with TRs found in this gene(s).&quot;</span>

top20_fav_genes &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="st">&quot;RBM3&quot;</span>, <span class="st">&quot;NOL11&quot;</span>, <span class="st">&quot;USP53&quot;</span>, <span class="st">&quot;TEX2&quot;</span>, <span class="st">&quot;HOOK1&quot;</span>, <span class="st">&quot;ZYG11B&quot;</span>, <span class="st">&quot;HSPA8&quot;</span>, <span class="st">&quot;DLAP&quot;</span>, <span class="st">&quot;SORT1&quot;</span>, <span class="st">&quot;DDX46&quot;</span>, <span class="st">&quot;FBXO7&quot;</span>, <span class="st">&quot;ABCD3&quot;</span>, <span class="st">&quot;NGLY1&quot;</span>, <span class="st">&quot;PARS2&quot;</span>, <span class="st">&quot;CLCC1&quot;</span>, <span class="st">&quot;AP3B1&quot;</span>, <span class="st">&quot;PRPSAP1&quot;</span>, <span class="st">&quot;PSMA5&quot;</span>, <span class="st">&quot;GRSF1&quot;</span>, <span class="st">&quot;CD274&quot;</span>)
(<span class="kw">getTRbyGene</span>(tr_fav_sp, <span class="dt">genes =</span> top20_fav_genes))
<span class="co">#&gt; [1] &quot;No protein with TRs found in this gene(s).&quot;</span>
<span class="co">#&gt; [1] &quot;No protein with TRs found in this gene(s).&quot;</span></code></pre></div>
</div>
<div id="compare-to-results-from-paulina" class="section level2">
<h2>compare to results from paulina</h2>
<p>She found those genes resp. proteins to have TRs</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">lina_top6_genes &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="st">&quot;CDX2&quot;</span>, <span class="st">&quot;CLK3&quot;</span>, <span class="st">&quot;CNPY3&quot;</span>, <span class="st">&quot;CRACR2B&quot;</span>, <span class="st">&quot;DPP7&quot;</span>, <span class="st">&quot;HSH2D&quot;</span>)
lina_top6_prots &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="st">&quot;Q9NQX5&quot;</span>, <span class="st">&quot;H3BVF8&quot;</span>, <span class="st">&quot;A0A0C4DFY8&quot;</span>, <span class="st">&quot;Q8N4Y2&quot;</span>, <span class="st">&quot;R4GMV4&quot;</span>, <span class="st">&quot;Q96JZ2&quot;</span>)</code></pre></div>
<p>Not all of them appear in the list of genes from  (22. Mai 2019)</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">lina_top6_genes <span class="op">%in%</span><span class="st"> </span>top20_unfav_genes
<span class="co">#&gt; [1] FALSE  TRUE  TRUE  TRUE  TRUE  TRUE</span></code></pre></div>
<p>And we couldn’t find TRs in all proteins mentioned in her thesis. Only in this subset:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">(<span class="kw">getTRbyGene</span>(<span class="dt">tr_sp =</span> tr_unfav_sp, <span class="dt">genes =</span> lina_top6_genes)[<span class="dv">1</span>])
<span class="co">#&gt;        ID</span>
<span class="co">#&gt; 60 Q96JZ2</span></code></pre></div>
</div>
</div>
<div id="comparative-analysis-of-favorable-trs-and-unfavorable" class="section level1">
<h1>Comparative analysis of favorable TRs and unfavorable</h1>
<p>TODO!!!!!!!!!</p>
</div>
<div id="disorderpropensity-meta-data" class="section level1">
<h1>Disorderpropensity Meta Data</h1>
<div id="disorderpropensity-per-protein" class="section level2">
<h2>Disorderpropensity per Protein</h2>
<p>TODO: Add what we want here</p>
<p>Start with determining the Amino Acid distribution of the TR Sequence</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># (aa_freq_TR &lt;- AAfreq_in_TR(Q9UGU0))</span></code></pre></div>
<p>We sort them according their disorderpropensity. You find more information in Uversky et al. ( <a href="http://www.tandfonline.com/doi/full/10.4161/idp.24684" class="uri">http://www.tandfonline.com/doi/full/10.4161/idp.24684</a>).</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># # Not mentioned in Uversky's paper: &quot;B&quot;, &quot;O&quot;, &quot;U&quot;, &quot;Z&quot;, &quot;X&quot;. These guys might need to fit in with the rest (if possible, as some of them represent multiple aa.)</span>
<span class="co"># aa_order_promoting_to_disorder_promoting = c(&quot;C&quot;, &quot;W&quot;, &quot;I&quot;, &quot;Y&quot;, &quot;F&quot;, &quot;L&quot;, &quot;H&quot;, &quot;V&quot;, &quot;N&quot;, &quot;M&quot;, &quot;R&quot;, &quot;T&quot;, &quot;D&quot;, &quot;G&quot;, &quot;A&quot;, &quot;K&quot;, &quot;Q&quot;, &quot;S&quot;, &quot;E&quot;, &quot;P&quot;, &quot;B&quot;, &quot;O&quot;, &quot;U&quot;, &quot;Z&quot;, &quot;X&quot;)</span>
<span class="co"># # Sort AA according to their disorder promoting potential</span>
<span class="co"># aa_freq_TR &lt;- aa_freq_TR[match(aa_order_promoting_to_disorder_promoting, aa_freq_TR$aa),]</span>
<span class="co"># colnames(aa_freq_TR) &lt;- c(&quot;aa_freq_tr&quot;, &quot;aa&quot;, &quot;aa_ratio_tr&quot;)</span></code></pre></div>
<p>We then load the dataset with information about the amino acid frequency of all swissprot proteins and the disorderpropensity of each amino acid. This data is included in the package and is generated through the script “/data-raw/create_AAfreqSP.R”. Rerunning this script, updates the amino acid frequency of swissprot proteins.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># data(&quot;AAfreqSP&quot;)</span></code></pre></div>
<p>We can now download the whole protein sequence and compare the Amino acid frequency compared to that of the overall protein</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># prot_seq &lt;- download_prot_sequence(&quot;Q9UGU0&quot;)</span>
<span class="co"># aa_freq_prot &lt;- AAfreq_in_prot(prot_seq)</span>
<span class="co"># (aa_freq_prot &lt;- aa_freq_prot[match(aa_order_promoting_to_disorder_promoting, aa_freq_prot$aa),])</span>
<span class="co"># colnames(aa_freq_prot) &lt;- c(&quot;aa_freq_sp&quot;, &quot;aa&quot;, &quot;aa_ratio_sp&quot;)</span></code></pre></div>
<p>Plot our amino acid abundancy in the TRs of this protein against the amino acid abundancy in the whole protein, we see that AA with medium to high disorderpropensity fall in the TR sequence.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># # we combine the datasets</span>
<span class="co"># aa_freq_prot &lt;- aa_freq_prot[1:20,]</span>
<span class="co"># disorderpropensity &lt;- AAfreqSP$disorderpropensity</span>
<span class="co"># df &lt;- cbind(aa_freq_TR[1:20,], disorderpropensity, aa_freq_prot)</span>
<span class="co"># df &lt;- df[ , !(names(df) %in% c(&quot;aa&quot;))]</span>
<span class="co"># </span>
<span class="co"># p &lt;- ggplot(df, aes(x= aa_ratio_sp, y = aa_ratio_tr, size = disorderpropensity))+</span>
<span class="co">#   geom_point()+</span>
<span class="co">#   labs(x= &quot;AA Background Frequency&quot;,</span>
<span class="co">#        y = &quot;AA Frequency in TRs&quot;)+</span>
<span class="co">#   guides(size=guide_legend(title=&quot;Disorderpropensity&quot;))+</span>
<span class="co">#   theme_minimal()</span>
<span class="co"># p &lt;- beautifier(p, x.axis.text.angle = 0)</span>
<span class="co"># p</span></code></pre></div>
</div>
<div id="disorderprotpensity-per-set-of-proteins" class="section level2">
<h2>Disorderprotpensity per Set of Proteins</h2>
</div>
</div>



<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
